Deficiency of Stomach-Type Claudin-18 in Mice Induces Gastric Tumor Formation Independent of H pylori Infection

Koya Suzuki; Kazuhiro Sentani; Hiroo Tanaka; Tomoki Yano; Kazuo Suzuki; Masanobu Oshima; Wataru Yasui; Atsushi Tamura; Sachiko Tsukita

doi:10.1016/j.jcmgh.2019.03.003

. 2019 Mar 23;8(1):119–142. doi: 10.1016/j.jcmgh.2019.03.003

Deficiency of Stomach-Type Claudin-18 in Mice Induces Gastric Tumor Formation Independent of H pylori Infection

Koya Suzuki ^1,^2,^∗,^∗∗∗, Kazuhiro Sentani ^3,^∗, Hiroo Tanaka ^1,^∗, Tomoki Yano ¹, Kazuo Suzuki ⁴, Masanobu Oshima ⁵, Wataru Yasui ³, Atsushi Tamura ^1,^∗, Sachiko Tsukita ^1,^∗∗

PMCID: PMC6554658 PMID: 30910700

Abstract

Background & Aims

Epithelial cells are joined by tight junctions (TJs) to form a cell sheet. In the stomach, epithelial cell sheet forms an essential barrier against gastric material, including gastric acid. Although the decreased expression of stomach-type claudin-18 (stCldn18), a TJ protein, is generally observed in human gastritis and gastric cancer, its pathological roles are not fully understood. We previously reported that mice lacking stCldn18 (stCldn18-/-) exhibit gastric acid leakage through TJs, which induces active gastritis at a young age. Here, we examined the gastric pathologies in mice after long-term stCldn18 deficiency.

Methods

The gastric pathologies in stCldn18-/- mice were sequentially analyzed from youth to old age, and compared to those in humans. To examine the relationship between stCldn18 deficiency-induced gastric pathologies and Wnt-dependent tumorigenesis, we generated Wnt1-overexpressing stCldn18-/- mice.

Results

StCldn18-/- mice developed chronic active gastritis at middle age, with expression of the chemoattractant CCL28. At old age, 20-30% of these mice developed gastric tumors with CXCL5 expression, indicative of EMT. In this process, spasmolytic polypeptide-expressing metaplasia (SPEM) cells appeared. Increased expressions of CD44-variants, TLR2, and CXCL5 indicated age-dependent changes in cell characteristics. Some features of the stCldn18-/- mouse gastric tumorigenesis resembled H pylori-infection-related human carcinogenesis. The gastric tumorigenesis was accelerated in Wnt1-overexpressing stCldn18-/- mice, indicating that Wnt is involved in the stCldn18-/- mouse gastric tumorigenesis.

Conclusions

StCldn18 deficiency induced gastric tumorigenesis in mice without H pylori infection. Our findings revealed that several signaling networks, including the cytokine-, stemness-, and Wnt-signaling pathways, may be activated under the stCldn18-deficiency-induced chronic active gastritis to accelerate the gastric tumorigenesis.

Keywords: Epithelial Barrier, Tight Junction, Chronic Active Gastritis, SPEM

Abbreviations used in this paper: Cldn, Claudin; DAPI, 4′,6-diamidino-2-phenylindole; DM, double-mutant; EMT, epithelial-mesenchymal transition; FBS, fetal bovine serum; FGP, fundic gland polyp; HBSS, Hank’s balanced salt solution; HP, hyperplastic polyp; IL, interleukin; luCldn18, lung-type claudin-18; MMP7, matrix metalloproteinase-7; PBS, phosphate-buffered saline; PJP, Peutz-Jeghers polyp; qRT-PCR, quantitative real-time polymerase chain reaction; RT-PCR, reverse-transcription polymerase chain reaction; SPEM, spasmolytic polypeptide–expressing metaplasia; stCldn18, stomach-type claudin-18; TJ, tight junction; TNF-α, tumor necrosis factor alpha; w.o., weeks old; Wnt1-Tg, Wnt1-overexpressing transgenic

Graphical abstract

See editorial on page 151.

Summary.

Stomach-type claudin-18 (stCldn18) deficiency induced gastric tumorigenesis in mice without H pylori infection. Several signaling networks, including the cytokine-, stemness-, and Wnt signaling pathways, may be activated under the stCldn18-deficiency–induced chronic active gastritis to accelerate the gastric tumorigenesis.

Accumulating evidence indicates that the tissue microenvironment plays critical roles in pathophysiological processes including tumor or cancer formation.1, 2, 3 Recent studies suggest that tumor or cancer microenvironments contain immune or nonimmune tumor-related cellular components, extracellular matrix, and interstitial components, which are enclosed by epithelial cell sheets endowed with permselective transcellular and paracellular barrier functions.4, 5, 6 While the epithelial transcellular barrier functions are defined by characteristics of the epithelial cells themselves, such as their plasma membranes and transporters or channels, the paracellular barrier functions are defined by the tight junctions (TJs) between the cells.7, 8, 9

Heliobacter pylori infection is a well-known risk factor for human gastritis and gastric cancer.¹⁰ H pylori infects the stomach epithelia and induces gastritis, in which epithelial cell hyperproliferation and dedifferentiation are induced by the CagA-SHP2-MAPK and Wnt signaling pathways.11, 12 These signaling pathways are thought to be critical causes of gastric carcinogenesis.11, 12 On the other hand, epithelial cell polarity and the cell-cell adhesion system including TJs are also dysregulated, through the CagA-PAR1 interaction.¹³ Thus, a disruption of the TJs’ paracellular barrier function, which is thought to cause gastric material including H⁺ to leak into the submucosal space, might be another important factor contributing to the progression of gastritis and gastric cancer.¹⁴ However, the contribution of the paracellular barrier dysfunction of TJs to gastric pathologies has not been well analyzed.

Claudins (Cldns), the 4-transmembrane domain proteins of TJs, are indispensable for TJ formation.7, 15, 16 Recent studies revealed that a lack of specific claudins causes inflammation-related pathological conditions.17, 18, 19, 20, 21 These conditions mainly result from aberrant microenvironments generated by the inappropriate passage of water, ions, or small solutes through dysregulated TJs.8, 22, 23

The expression of stomach-type Cldn18, a predominant and essential Cldn for gastric TJs, is generally decreased in various types of human gastritis and gastric cancer, with or without H pylori infection.¹⁴ Recently, a Cldn18-ARHGAP fusion gene that disturbs the paracellular barrier function of TJs was also reported in human gastric cancer.²⁴ Furthermore, we previously reported that stomach-type Cldn18 gene-knockout (stCldn18–/–) mice show acute oxyntic atrophic gastritis at a young age, induced by gastric acid (H⁺) leakage from the gastric lumen to the submucosal space through stCldn18–/– TJs.14, 25 While it is generally accepted that tumor or cancer microenvironments can be created under chronic inflammatory conditions,²⁶ it remains unknown whether gastric tumorigenesis or carcinogenesis can also be induced after a long period of stCldn18-deficiency–induced gastritis. Consistent with a recent report analyzing stCldn18–/– mice, here we independently revealed that gastric tumors developed in aged stCldn18–/– mice even without H pylori infection.²⁷ Furthermore, we found that several signaling networks, including the cytokine-, stemness-, and Wnt-signaling pathways, may be activated under the stCldn18-deficiency–induced chronic active gastritis to accelerate the gastric tumorigenesis.

Results

Induction of Oxyntic Atrophic Gastritis in Young stCldn18–/– Mice and Gastric Tumor Development in Aged stCldn18–/– Mice

To examine the long-term effects of the stCldn18 deficiency on the gastric pathology, we analyzed stCldn18–/– mice at 8, 40, 60, and 100 weeks old (w.o.) (Figure 1A and B). We previously reported that stCldn18–/– mice exhibit oxyntic atrophic gastritis induced by gastric acid leakage from the gastric lumen into the submucosal space at a young age (<8 w.o.).¹⁴ The obvious histological finding in the stCldn18–/– mouse stomach was pseudopyloric metaplasia.¹⁴ In this study, we further found that gastric tumors developed in 20%–30% of the stCldn18–/– mice at older ages (>60 w.o.) (Figure 1A and B). As the gastric tumors did not appear in middle-aged stCldn18–/– mice (40 w.o.) (Figure 1A and B), the tumorigenic event might occur between the ages of 40 and 60 w.o.

Irregular Differentiation and Proliferation of Gastric Epithelial Cells in Young and Aged stCldn18–/– Mice

As gastric hyperplasia developed in the stCldn18–/– mice (>40 w.o.) (Figure 1B), we examined the age-dependent changes in the differentiation and proliferation of gastric epithelial cells. The number of H,K-ATPase–positive parietal cells was decreased in the stCldn18–/– mice at all ages (Figure 2A). Ki-67–positive proliferative cells were observed in the bottom region of the gastric glands in the young stCldn18–/– mouse stomach (8 w.o.) (Figure 2B). The width of the proliferative zone was increased in the middle-aged stCldn18–/– mouse stomach (40 w.o.), and the Ki-67–positive proliferative cells became sparser in the old stCldn18–/– mouse stomach (>60 w.o.) (Figure 2B). In contrast, the Ki-67–positive proliferative cells were located only in the neck region of the gastric glands in the stCldn18+/+ mice at all ages (Figure 2B). These results suggested that in the stCldn18–/– mice, oxyntic atrophic gastritis with abnormal cell differentiation and proliferation occurred at all ages.

Transition From Active to Chronic Active Gastritis in Middle-Aged stCldn18–/– Mice

It is generally accepted that tumor microenvironments can be created under chronic inflammatory conditions.²⁶ In the young stCldn18–/– mice (8 w.o.), Gr1-positive neutrophils predominantly infiltrated the stomach (Figure 3A and B), and only low numbers of CD3⁺ T lymphocytes were observed (Figure 3C), suggesting that acute but not chronic gastritis was present. However, infiltrating CD3⁺ T lymphocytes were observed in the vicinity of the gastric glands in the stomach of stCldn18–/– mice from middle age (>40 w.o.) (Figure 3C). Consistent with this result, the number of infiltrating CD4⁺, and CD8⁺ T lymphocytes was increased in the stomach of stCldn18–/– mice from middle age (>40 w.o.) (Figure 3D). Gr1-positive-neutrophils were continuously detected in the stomach of stCldn18–/– mice from middle age (>40 w.o.) (Figure 3A and B), similar to H pylori infection–related gastritis.²⁸ These data indicated that in the stCldn18–/– mice, active gastritis transitioned to chronic active gastritis between youth and middle age.

Activation of Inflammatory Signaling including CCL28 and CXCL5 in Middle-Aged stCldn18–/– Mice

As active gastritis transitioned to chronic active gastritis in the stCldn18–/– mice with age, we further analyzed the inflammatory signaling associated with the gastritis and the gastric tumorigenesis. The expression levels of general inflammatory cytokines such as interleukin (IL)-1β, tumor necrosis factor alpha (TNF-α), and CXCL1 were upregulated in the stomach of stCldn18–/– mice (Figure 4A).

**Activation of inflammatory signals including CCL28 and CXCL5 in aged *stCldn18–/–* mice.** (A) Expression levels of IL-1β, TNF-α, and CXCL1 in the stomach from *stCldn18+/+* (n = 8, 4, 11, 10) and *stCldn18–/–* mice (n = 14, 4, 13, 16) (8, 40, 60, and 100 w.o.) quantified by qRT-PCR. Gene expressions were normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Results are expressed as mean ± SD. Comparisons between 2 groups were performed using Student’s t test, and differences with *P <* .05 were considered statistically significant. **P <* .05; ***P <* .01. (B) Immunofluorescence micrographs for CXCL5 (*green*) co-stained with α-catenin (*red*) and DAPI (*blue*) in the stomach from *stCldn18+/+* mice and *stCldn18–/–* mice (8, 40, 60, and 100 w.o.). CXCL5 signals were clearly observed in the stomach of *stCldn18–/–* mice after middle-age (40, 60, and 100 w.o.) (*arrows*). High-magnification images are shown in insets. Representative images from at least 3 independent experiments are shown. Scale bars = low magnification: 50 μm, high magnification: 10 μm. (*Right*) Expression level of CXCL5 in the stomach from *stCldn18+/+* (n = 8, 4, 12, 10) and *stCldn18–/–* mice (n = 6, 4, 13 16) (8, 40, 60, and 100 w.o.) quantified by qRT-PCR. Gene expressions were normalized to GAPDH. Results are expressed as mean ± SD. Comparisons between 2 groups were performed using Student’s t test, and differences with *P <* .05 were considered statistically significant. ***P <* .01. (C) Expression levels of STAT3, IKKβ, and NF-κB in the stomach from *stCldn18+/+* (n = 4, 4, 10, 10) and *stCldn18–/–* mice (n = 6, 4, 12, 16) (8, 40, 60, and 100 w.o.) quantified by qRT-PCR. Gene expressions were normalized to GAPDH. Results are expressed as mean ± SD. Comparisons between 2 groups were performed using Student’s t test, and differences with *P <* .05 were considered statistically significant. **P <* .05; ***P <* .01. (D) (*Left*) Immunofluorescence micrographs for CCL28 (*green*), a lymphocyte chemoattractant and maintainer of chronic inflammation, co-stained with α-catenin (*red*) and DAPI (*blue*) in the stomach from *stCldn18+/+* and *stCldn18–/–* mice (10, 40, 60, and 100 w.o.). CCL28 signals were clearly observed in the stomach of the *stCldn18–/–* mice after middle-age (40, 60, and 100 w.o.) (*arrows*). High-magnification images are shown in insets. Representative images from at least 3 independent experiments are shown. Scale bars = low magnification: 50 μm, high magnification: 10 μm. (*Right*) Expression level of CCL28 in the stomach from *stCldn18+/+* (n = 8, 4, 12, 10) and *stCldn18–/–* (n = 10, 4, 13 16) mice (8, 40, 60, and 100 w.o.) quantified by qRT-PCR. Gene expressions were normalized to GAPDH. Results are expressed as mean ± SD. Comparisons between 2 groups were performed using Student’s t test, and differences with *P <* .05 were considered statistically significant. ***P <* .01. (E) Expression levels of CXCL5, IKKβ, NFκB, and ASCL2 in the stomach from *stCldn18+/+* and *stCldn18–/–* mice (around 50 w.o.) after POL7085 or cimetidine treatment, quantified by qRT-PCR (n: *stCldn18–/–* = 7, 5, 6, given saline, POL7085, and cimetidine, respectively). Gene expressions were normalized to GAPDH. Results are expressed as mean ± SD. Comparisons between 2 groups were performed using Student’s t test, and differences with *P <* .05 were considered statistically significant. **P <* .05; ***P <* .01.

In H pylori infection–related gastritis and gastric cancer, some cytokines are reported to be related to the disease severity or survival rate.29, 30, 31, 32 Among them, CXCL5, a multi-functional cytokine with neutrophil-attracting, angiogenic, and epithelial-mesenchymal transition (EMT)–inducing activities, is related to the severity of H pylori infection–related human gastric cancer.33, 34, 35 We observed CXCL5-positive gastric epithelial cells in the stCldn18–/– mice from middle age (>40 w.o.) (Figure 4B). Consistent with this finding, the expression level of CXCL5 was significantly increased in the stomach of stCldn18–/– mice at old ages (>60 w.o.) (Figure 4B).

The expression levels of other inflammation-related genes, including STAT3, IKKβ, and NFκB, were also upregulated in the stomach of stCldn18–/– mice (Figure 4C). IKKβ/NF-κB activation and STAT3 activation are known to have tumorigenic roles, such as in hyperproliferation, antiapoptosis, and angiogenesis.36, 37, 38, 39

CCL28, a chemokine with a chemoattractant activity for lymphocytes, is upregulated in H pylori infection–related human gastritis, and is of 6 genes that are reported to be significantly correlated with the aggressiveness of gastric cancer.32, 40, 41, 42, 43 We observed CCL28-positive cells in the stomach of stCldn18–/– mice from middle age (>40 w.o.) (Figure 4D). The expression level of CCL28 was also increased in the stomach of stCldn18–/– mice, especially at old age (>60 w.o.) (Figure 4D). To further examine CCL28’s contribution to the stCldn18–/– mouse gastritis, POL7085, an inhibitor of the CCL28-CCR10 cascade,44, 45 was administered to the stCldn18–/– mice. After 1 week of POL7085 administration, the expression levels of inflammation-related genes such as CXCL5, NF-kB, and IKKβ were dramatically decreased in the middle-aged stCldn18–/– mice (around 50 w.o.) (Figure 4E). Thus, CCL28 may be a key cytokine for inducing chronic active gastritis in the stCldn18–/– mice.

Collectively, our results showed that CCL28 may be involved in the transition from active gastritis to chronic active gastritis in the stCldn18–/– mice. In addition, the upregulation of other inflammatory signals such as CXCL5, STAT3, and IKKβ/NF-κB could be indicative of tumor-directed changes, such as EMT, hyperproliferation, antiapoptosis, and angiogenesis, in the stCldn18–/– mice.

Induction of Spasmolytic Polypeptide–Expressing Metaplasia in Young and Aged stCldn18–/– Mice

Recently, spasmolytic polypeptide–expressing metaplasia (SPEM) was suggested to be the origin of cancer stem cells.⁶ We previously reported that young stCldn18–/– mice exhibit SPEM, which was probably caused by the acute decrease in the number of parietal cells due to gastric acid leakage.¹⁴ In the present study, we found that aged stCldn18–/– mice (around 50 w.o.) also showed SPEM, which was double-positive for TFF2 and Pepsin C, near the bottom of the gastric glands (Figure 5A). Ki-67 staining showed that the TFF2 and Pepsin C double-positive SPEM cells were proliferative (Figure 5A).

**Induction of spasmolytic polypeptide–expressing metaplasia (SPEM) in young and aged *stCldn18–/–* mice.** (A) Immunofluorescence micrographs for TFF2 (*green*) and Pepsin C (*blue*) as SPEM cell markers co-stained with Ki-67 (*red*) and DAPI (*white*) in the stomach from *stCldn18+/+* and *stCldn18–/–* mice (around 50 w.o.). Right panels are magnified images of the boxed regions in the left panels. SPEM cells were clearly observed in the stomach of the *stCldn18–/–* mice. The Ki-67 signals partially coincided with the SPEM cells (*arrows*). Representative images from at least 2 independent experiments are shown. Scale bars = 100 μm. (B) Expression levels of the tumor-related alternatively spliced variants of CD44, and GAPDH in the stomach from *stCldn18+/+* and *stCldn18–/–* mice (8, 40, 60, and 100 w.o.) quantified by conventional RT-PCR. (C) Immunofluorescence micrographs for TFF2 (*green*) and Pepsin C (*blue*) as SPEM cell markers co-stained with CD44 (*red*) and DAPI (*white*) in the stomach from *stCldn18+/+* and *stCldn18–/–* mice (around 50 w.o.). Right panels are magnified images of the boxed regions in the left panels. CD44-positive cells were clearly observed in the stomach of the *stCldn18–/–* mice. The CD44 signals partially coincided with the SPEM cells (*arrows*). Representative images from at least 3 independent experiments are shown. Scale bars = 100 μm.

Upregulation of CD44 Splicing Variants in Middle-Aged stCldn18–/– Mice

SPEM cells are known to express splicing variants of CD44, which are often found at high expression levels in cancer stem cells.46, 47, 48, 49 In this respect, conventional real-time polymerase chain reaction (RT-PCR) showed that the CD44 v8-v10 variants were highly expressed in the stomach of stCldn18–/– mice from middle age (>40 w.o.) (Figure 5B), and CD44-positive SPEM cells were observed in the stomach of aged stCldn18–/– mice (Figure 5C). These results suggested that the tumor-directed stemness of the SPEM cells increased in the stCldn18–/– mice. Supporting this hypothesis, the expression level of TLR2, an innate immune receptor with a role in maintaining stemness,⁵⁰ increased in the stCldn18–/– mice with age (Figure 6A). We also found CD44 and TLR2 double-positive cells in the stomach of stCldn18–/– mice (Figure 6B). In addition, the expression levels of other stemness markers such as SOX2, c-Myc, Ascl2, and matrix metalloproteinase-7 (MMP7) were increased in the stomach of the aged stCldn18–/– mice (Figure 6C).⁵¹ The expression level of MMP7 was especially increased in the stomach of stCldn18–/– mice at 100 w.o., which is notable because MMP7 is known to be involved in cell invasion and in the stemness of cancer stem cells.⁵¹

**Upregulation of TLR2 in aged *stCldn18–/–* mice.** (A) (*Left*) Immunofluorescence micrographs for TLR2 (*green*) co-stained with α-catenin (*red*) and DAPI (*blue*) in the stomach from *stCldn18+/+* and *stCldn18–/–* mice (8, 40, 60, and 100 w.o.). High-magnification images are shown in insets. TLR2-positive cells were clearly observed in the stomach of *stCldn18–/–* mice after middle age (40, 60, and 100 w.o.). At middle age (40 w.o.), the TLR2-positive cells did not show the characteristics of gastric epithelium (*arrowheads*), but at old age (60, and 100 w.o.), the TLR2-positive cells might have been gastric epithelial cells (*arrows*). Representative images from at least 2 independent experiments are shown. Scale bars = low magnification: 50 μm, high magnification: 50 μm. (*Right*) Expression level of TLR2 in the stomach from *stCldn18+/+* (n = 4, 4, 10, 10) and *stCldn18–/–* mice (n = 8, 4, 12, 16) (8, 40, 60, and 100 w.o.) quantified by qRT-PCR. Results are expressed as mean ± SD. Comparisons between 2 groups were performed using Student’s t test, and differences with *P <* .05 were considered statistically significant. ***P <* .01. (B) Immunofluorescence micrographs for CD44 (*green*), co-stained with TLR2 (*red*) in the stomach from *stCldn18+/+* and *stCldn18–/–* mice (100 w.o.). High-magnification images are shown in insets. CD44-and TLR2-double-positive cells were clearly observed in the stomach of the *stCldn18–/–* mice (*arrows*). Representative images from at least 3 independent experiments are shown. Scale bars = low magnification: 50 μm, high magnification: 50 μm. (C) Expression levels of c-Myc, hypoxia-inducible factor HIF2a, MMP7, SOX2, and ASCL2 in the stomach from *stCldn18+/+* (n = 5, 4, 12, 9) and *stCldn18–/–* (n = 9, 4, 13, 16) mice (8, 40, 60, and 100 w.o.) quantified by qRT-PCR. The expression level of MMP7 was especially increased in the stomach of the 100 w.o. *stCldn18–/–* mice. Gene expressions were normalized to GAPDH. Results are expressed as mean ± SD. Comparisons between 2 groups were performed using Student’s t test, and differences with *P <* .05 were considered statistically significant. **P <* .05; ****P <* .001.

Development of Intestinal Metaplasia and Ectopic Gastric Glands in Aged stCldn18–/– Mice

Gastric intestinal metaplasia is known to be a precancerous change in which the gastric mucosa is replaced by intestinal epithelium.⁵² In this respect, the expression levels of Cldn2, Cldn4, and Cldn7 were significantly increased in the stomach of stCldn18–/– mice (Figure 7A), and these Cldns are known to be highly expressed in intestinal epithelial cells.⁵³ Consistent with this finding, Cldn2- or Cldn7-positive cells were clearly observed in the stomach of stCldn18–/– mice (Figure 7B). Furthermore, villin, a marker for intestinal epithelial cells, was detected in the stomach of stCldn18–/– mice (Figure 7B). These results suggested that gastric intestinal metaplasia developed in the stCldn18–/– mice. Importantly, the changes in the expression levels of these Cldns could also be associated with the gastric pathologies of the stCldn18–/– mice.

**Development of intestinal metaplasia and ectopic gastric gland in aged *stCldn18–/–* mice.** (A) Expression levels of *Cldns* in the stomach from stCldn18+/+ (n = 6), and *stCldn18–/–* (n = 7), mice at 100 w.o. quantified by qRT-PCR. The expression levels of *Cldn2*, 4, 7, and *luCldn18* were significantly increased in the stomach of *stCldn18–/–* mice at old age. Gene expressions were normalized to GAPDH. Results are expressed as mean ± SD. Comparisons between 2 groups were performed using Student’s t test, and differences with *P <* .05 were considered statistically significant. n.s., not significant. **P <* .05. (B) Immunofluorescence micrographs for Cldn2 or Cldn7 (*green*) co-stained with E-cadherin (*red*) and with or without villin (*blue*) in the stomach from *stCldn18+/+* and *stCldn18–/–* mice (around 50 w.o.). Representative images from at least 3 independent experiments are shown. Scale bars = 100 μm. (C) Hematoxylin and eosin–stained images of the ectopic gastric gland in aged *stCldn18–/–* mice. Ectopic gastric glands were found in 1 of 3 old *stCldn18–/–* mice by examining stomach tissue slices. Right panels are magnified images of the boxed regions in the left panels. Representative images from at least 2 independent experiments are shown. Scale bars = 100, 50, 10 μm, left to right panel. (D) (*Left*) Immunofluorescence micrographs for TFF2 (*green*) and Pepsin C (*blue*) as SPEM cell markers co-stained with CD44 (red) and DAPI (*white*) in the ectopic gastric gland from *stCldn18–/–* mice (around 50 w.o.). (Right) Representative immunofluorescence micrographs for TFF2 (*green*), and Pepsin C (*blue*) as SPEM cell markers co-stained with Ki-67 (*red*) and DAPI (*white*) in the ectopic gastric gland from *stCldn18–/–* mice (around 50 w.o.). *Right* panels are magnified images of the boxed regions in the left panels. Representative images from at least 2 independent experiments are shown. Scale bars = 100, 50 μm, left to right panel. (E) (*Left*) Immunofluorescence micrographs for *Cldn2* (*green*) co-stained for E-cadherin (*red*) and villin (*blue*) in the ectopic gastric gland from *stCldn18–/–* mice (around 50 w.o.). Right panels are magnified images of the boxed regions in the left panels. Representative images from at least 2 independent experiments are shown. Scale bars = 100, 50 μm, left to right panel. (*Middle, Right*) Immunofluorescence micrographs for *Cldn4* or *Cldn7* (*green*) co-stained for E-cadherin (*red*) in the ectopic gastric gland from *stCldn18–/–* mice (around 50 w.o.). Right panels are magnified images of the boxed regions in the left panels. Representative images from at least 2 independent experiments are shown. Scale bars = 100, 50 μm, left to right panel.

In the old stCldn18–/– mice (100 w.o.), ectopic gastric glands formed outside the gastric mucosa (Figure 7C). This ectopic gastric gland was histologically similar to the “gastritis cystica profunda” or to the “invasive submucosal gland,” which are observed in H pylori–related gastritis,⁵⁴ and it was recently reported that the “invasive submucosal gland” represents the stage between intestinal metaplasia and gastric cancer in a study in Mongolian gerbils.⁵⁵ Although the ectopic gastric gland we observed had features of intestinal epithelium, which is villin-, Cldn2-, Cldn4-, or Cldn7-positive (Figure 7E), in addition to being CD44- or Ki-67–positive (Figure 7D), it did not show any obvious dysplastic changes such as nuclear atypia.

Activation of Wnt Signaling in Aged stCldn18–/– Mice

Wnt signaling is known to be activated in 30%–50% of human gastric cancers.⁵⁶ Considering that CXCL5, CD44, and MMP7, which were upregulated in the aged stCldn18–/– mouse stomach, are related to be Wnt signaling,57, 58, 59 Wnt signaling might be involved in the stCldn18–/– mouse gastric tumorigenesis. In this respect, the nuclear localization of β-catenin, a marker for Wnt signaling activation,⁶⁰ was observed in the stomach of stCldn18–/– mice from middle age (>40 w.o.) (Figure 8A). Furthermore, the expression level of Wnt1a was especially increased in the stomachs with gastric tumors of 100-w.o. stCldn18–/– mice (Figure 8B). The expression levels of Wnt4 and Wnt5 gradually increased in the stomach of stCldn18–/– mice with age (Figure 8C). These results showed that Wnt signaling was increasingly activated in the stomach of stCldn18–/– mice with age. Thus, the activation of Wnt signaling could be related to the gastric tumorigenesis in stCldn18–/– mice.

Acceleration of Gastric Tumorigenesis Under Chronic Active Gastritis in Wnt1-Overexpressing Transgenic stCldn18–/– Double-Mutant Mice

As previously reported, Wnt1-overexpressing transgenic (Wnt1-Tg) mice developed small gastric polyps without severe gastritis.⁶¹ To examine the relationship between stCldn18-deficiency–induced chronic gastritis and Wnt-dependent gastric tumorigenesis, we crossed Wnt1-Tg with stCldn18–/– mice to obtain double-mutant (DM) mice. The Wnt1-Tg and DM mice were born, and grew with a macroscopically normal appearance, similar to the stCldn18–/– mice.

At a young age (8 w.o.), the Wnt1-Tg mice showed no severe gastric pathologies, in contrast to the stCldn18–/– and DM mice (Figure 9A–C). The DM mouse stomach also showed increased expression levels of inflammatory cytokines such as IL-1β, TNF-α, CXCL1, and CCL28, similar to the stCldn18–/– mouse stomach (Figure 9B). A few CD3⁺ T lymphocytes were observed in the DM mouse stomach (Figure 9C). These results indicated that at the young age (8 w.o.), the DM mice developed gastritis similarly to the stCldn18–/– mice.

**No tumor formation in young *Wnt1*-Tg *stCldn18–/–* DM mice.** (A) Hematoxylin and eosin–stained images of the stomach from *stCldn18+/+*, *Wnt*1-Tg, *stCldn18–/–*, and *Wnt1*-Tg mice crossed with *stCldn18–/–* DM mice at a young age (8 w.o.). No obvious difference was detected in the stomachs between *stCldn18–/–* and DM mice at the young age. Representative images from at least 3 independent experiments are shown. Scale bars = 1 mm. (B) Expression levels of IL-1β, TNF-α, CXCL1, CCL28, and CXCL5 in the stomach from stCldn18+/+, *Wnt1*-Tg, *stCldn18–/–*, and DM mice at a young age (8 w.o.) quantified by qRT-PCR (n = 8, 4, 10, 11). No significant differences were detected between the stomachs of *stCldn18–/–* and DM mice at the young age. Gene expressions were normalized to GAPDH. Results are expressed as mean ± SD. Comparisons among more than 3 groups were performed using the Kruskal-Wallis 1-way analysis of variance on ranks (*P <* .01) followed by the Steel-Dwass test. **P <* .05. (C) Immunofluorescence micrographs for CD3 or CXCL5 (*green*) co-stained with ZO-2 (*red*) and DAPI (*blue*) in the stomach from stCldn18+/+, *Wnt1*-Tg, *stCldn18–/–*, and DM mice at a young age (8 w.o.). High-magnification images are shown in insets. No significant differences were detected between the stomachs of *stCldn18–/–* and DM mice at the young age. Representative images from at least 3 independent experiments are shown. Scale bars = low magnification: 100μm, high magnification: 10 μm.

At middle age (40 w.o.), all of the DM mice developed gastric tumors, while none of the stCldn18–/– mice did (Figure 10A). Hematoxylin and eosin–stained images of the DM mouse stomach showed that the density of the gastric glands was increased in a back-to-back manner (Figure 10B), suggesting that dysplastic changes were induced. Inflammatory cytokines such as IL-1β, TNF-α, CXCL1, CCL28, and CXCL5 were upregulated in both the stCldn18–/– and DM mouse stomachs (Figure 10C). The number of CD3⁺ T lymphocytes was also increased in the stCldn18–/– and the DM mouse stomach compared with the stCldn18+/+ mouse and Wnt1-Tg mouse stomach (Figure 10D). At this age, the Wnt1-Tg mice did not show severe gastritis/gastric tumor formation but small foveolar hyperplasia, the phenotype of which was reported previously (Figure 10A–D).⁶¹

**Accelerated gastric tumorigenesis under chronic active gastritis in aged *Wnt1*-Tg *stCldn18–/–* DM mice.** (A) Macroscopic images of the stomach from *stCldn18+/+*, *Wnt1*-Tg, *stCldn18–/–*, and DM mice at middle age (40 w.o.). Gastric tumors were observed in all of the stomachs of DM mice but not of *stCldn18–/–* mice at middle age (40 w.o.). Representative images from at least 3 independent experiments are shown. Scale bars = 1 cm. (B) Hematoxylin and eosin–stained images of the stomach from *stCldn18+/+*, *Wnt1*-Tg, *stCldn18–/–*, and DM mice at middle age (40 w.o.). Dysplastic changes were observed in the stomach of DM mice at middle age (40 w.o.). Representative images from at least 2 independent experiments are shown. Scale bars = low magnification = 1 mm, high magnification = 50 μm. (C) Expression levels of IL-1β, TNF-α, CXCL1, CCL28, and CXCL5 in the stomach from stCldn18+/+, *Wnt1*-Tg, *stCldn18–/–*, and DM mice at middle age (40 w.o.) quantified by qRT-PCR (n = 4, 4, 4, 5). The expression levels of IL-1β, CCL28, and CXCL5 were increased in the stomach of *stCldn18–/–* and DM mice compared with those of *stCldn18+/+* and *Wnt1*-Tg mice at middle age. Gene expressions were normalized to GAPDH. Results are expressed as mean ± SD. Comparisons among more than 3 groups were performed using the Kruskal-Wallis 1-way ANOVA on ranks (*P <* .01) followed by the Steel-Dwass test. no symbol, not significant. (D) Immunofluorescence micrographs for CD3 or CXCL5 (*green*) co-stained with ZO-2 (*red*) and DAPI (*blue*) in the stomach from *stCldn18+/+*, *Wnt1*-Tg, *stCldn18–/–*, and DM mice at middle age (40 w.o.). The levels of CD3- and CXCL5-positive cells (*arrows*) were increased in the stomach of *stCldn18–/–* and DM mice at middle age (40 w.o.). High-magnification images are shown in insets. Representative images from at least 3 independent experiments are shown. Scale bars = 50 μm, 10 μm.

Collectively, the extent of gastritis in the DM mice was similar to that in the stCldn18–/– mice, except for the level of CXCL5, which is a target of Wnt signaling. (Figure 10A–D). These findings suggested that the Wnt-dependent gastric tumorigenesis might be accelerated under the severe gastritis induced by the stCldn18 deficiency.

Similarity of Gastric Tumorigenesis in stCldn18–/– Mice to H pylori Infection–Related Tumorigenesis in Humans

To compare the mouse model and human disease, we analyzed the expression levels of Cldn18 in human gastritis samples and in various human gastric tumors. Gastric hyperplastic polyp (HP), which is usually associated with H pylori infection in humans, develops in the context of chronic inflammation.⁶² Fundic gland polyp (FGP), a major human tumor, is a hyperplasia that is not associated with either inflammation or H pylori infection, and is considered to be different from the inflammation-related process such as that seen in the stCldn18–/– mice.⁶³ Another disease, Peutz-Jeghers polyp (PJP), is an autosomal-dominant inherited disorder characterized by hamartoma in the digestive tract, including gastric tumors, and also has a different disease process from that seen in the stCldn18–/– mice.⁶⁴

Pathologically, the tumor regions in the stCldn18–/– mice closely resembled human HP (Figure 11A). The expression level of Cldn18 in HP was clearly lower than that in FGP or PJP (Figure 11B), and the expression level of CXCL5 in HP was clearly higher than that in FGP or PJP (Figure 11C). These results suggested that the expression level of Cldn18 was inversely correlated with that of CXCL5 in HP. These data suggested that the stCldn18–/– mouse gastric tumors at least partly resembled human HP.

**Inverse correlation between the expression levels of *Cldn18* and CXCL5 in human HP and cancer.** (A) Hematoxylin and eosin–stained images of human HP, FGP, and PJP. These gastric tumors are the result of *H pylori* infection, a side effect of proton pump inhibitor therapy, and an inherited gastric tumor of hamartoma/hyperplasia, respectively. Lower panels are magnified images of the boxed regions in the upper panels. Representative images from at least 3 independent experiments are shown. Scale bars = 1 mm and 200 μm in the upper and lower panels, respectively. (B) (*Left*) Immunohistological micrographs for *Cldn18* in human HP, FGP, and PJP. Lower panels are magnified images of the boxed regions in the upper panels. Representative images from at least 3 independent experiments are shown. Scale bars = 1 mm and 200 μm in the upper and lower panels, respectively. (*Right*) In the graphs, 4+: 75%–100%, 3+: 50%–75%, 2+: 25%–50%, 1+: 1%–25%, 0: 0% of the epithelial cells were stained. The number of Cldn18-positive gastric epithelial cells was significantly decreased in human HP compared with FGP and PJP. (C) (*Left*) Immunohistological micrographs for CXCL5 in human HP, FGP, and PJP. Lower panels are magnified images of the boxed regions in the upper panels. Representative images from at least 3 independent experiments are shown. Scale bars = 1 mm and 200 μm in the upper and lower panels, respectively. (*Right*) In the graphs, 4+: 75%–100%, 3+: 50%–75%, 2+: 25%–50%, 1+: 1%–25%, 0: 0% of the epithelial cells were stained. The number of CXCL5-positive gastric epithelial cells (*arrows*) was significantly increased in human HP compared with FGP and PJP. (D) (*Left*) Hematoxylin and eosin–stained images of a human gastric adenoma. Lower panels are magnified images of the boxed regions in the upper panels. Representative images from at least 2 independent experiments are shown. Scale bars = 1 mm and 200μm in the upper and lower panels, respectively. (*Middle, Right*) Immunohistological micrographs for claudin-18 and CXCL5 in the human gastric adenoma. Lower panels are magnified images of the boxed regions in the upper panels. Representative images from at least 2 independent experiments are shown. Scale bars = 1 mm and 200 μm in the upper and lower panels, respectively.

Furthermore, we noted that the Cldn18 expression level in a gastric adenocarcinoma that originated from HP was reduced (Figure 11D). The CXCL5 expression were also upregulated in the adenocarcinoma region of the human stomach (Figure 11D).

Toxic Effects of Gastric Acid in Aged stCldn18–/– Mice

In the stCldn18–/– mice, the long-term gastritis continued without healing. In this respect, only a few parietal cells remained in the aged stCldn18–/– mice, suggesting that gastric acid secreted by these cells promoted the gastritis. After 1 week of administering the H₂-blocker cimetidine, an inhibitor of gastric acid secretion, to middle-aged stCldn18–/– mice (around 50 w.o.), the expression levels of inflammation-related genes such as CXCL5, IKKβ, and NF-kB were dramatically decreased (Figure 4E). This result suggested that the remaining parietal cells could still secrete gastric acid to promote gastritis.

Importantly, it was still unclear to what extent the gastric acid leakage due to the stCldn18 deficiency directly contributed to the gastritis and gastric tumorigenesis. Our present findings suggested that the activation of several signaling pathways, including the cytokine-, stemness-, and Wnt-signaling pathways, might contribute to these gastric pathologies under the severe gastritis induced by the stCldn18 deficiency. For example, the administration of cimetidine or POL7085 dramatically inhibited the gastritis, and also decreased the expression level of Ascl2, a stemness marker, in middle-aged stCldn18–/– mice (around 50 w.o.) (Figure 4E). Thus, it was possible that the stemness was also increased under the chronic gastritis induced by the stCldn18 deficiency.

Process of Gastric Tumorigenesis in Young to Aged stCldn18–/– Mice Without H pylori Infection

Based on our findings, we propose a scheme in which the loss of stCldn18 creates a microenvironment that leads to chronic active gastritis and gastric tumor formation in the absence of H pylori infection (Figure 12). The active gastritis, which occurred in young stCldn18–/– mice (<8 w.o.), transitioned to chronic active gastritis with expression of the chemoattractant CCL28 in middle-aged stCldn18–/– mice (40 w.o.). In the old stCldn18–/– mice (>60 w.o.), gastric tumors formed with the expression of CXCL5, which promoted EMT downstream of Wnt. In this tumorigenesis process, SPEM cells appeared. Changes in cell characteristics were suggested by the upregulation of CD44, TLR2, and Wnt. Furthermore, the gastric tumorigenesis was accelerated in Wnt1-Tg stCldn18–/– DM mice.

**Schematic illustration of the signaling pathways in *stCldn18–/–* mouse gastric tumorigenesis.** Scheme of the signaling pathways in *stCldn18–/–* mouse gastric tumorigenesis. In the gastric tumorigenesis of *stCldn18–/–* mice, several signaling pathways, including the cytokine-, stemness-, and Wnt- signaling pathways, may be activated to accelerate gastric tumorigenesis under the *stCldn18* deficiency–induced chronic active gastritis.

Our analysis provides evidence that long-term stCldn18 deficiency induces chronic active gastritis and then gastric tumors in mice even in the absence of H pylori infection. Several signaling pathways, including the cytokine-, stemness-, and Wnt-signaling pathways, may be activated to accelerate the gastric tumorigenesis under the stCldn18 deficiency–induced chronic active gastritis. Notably, the process of stCldn18–/– mouse gastric tumorigenesis partially resembled that of H pylori infection–related human carcinogenesis.

Discussion

Disruption of the paracellular barrier function of TJs is thought to be an important factor in the progression of gastritis and gastric cancer,¹⁴ although its contribution to gastric pathologies has not been thoroughly analyzed. In this respect, we previously reported that in young stCldn18–/– mice, acute oxyntic atrophic gastritis is induced by the leakage of gastric acid from the gastric lumen to the submucosal space through stCldn18–/– TJs. In the present study, we analyzed the stCldn18–/– mice over their entire lifetime. Our analysis provides evidence that long-term stCldn18 deficiency induces gastric tumors to form under chronic active gastritis in mice without H pylori infection, in a process involving several signaling pathways, including the cytokine-, stemness-, and Wnt-signaling–activated pathways.

CCL28 could be a key chemokine causing the stCldn18–/– mouse gastritis to become chronic, based on the following findings. The expression of CCL28 is reported to be induced by hypoxia-inducible factors under hypoxic conditions,⁴² suggesting that hyperproliferative tumor-related hypoxia could upregulate CCL28 expression in the stCldn18–/– mice (Figure 6C). It is also reported that the expression of CD44 v8-v10 variants is induced by hypoxia to promote cell proliferation.⁶⁵ Thus, a positive feedback loop involving CD44 upregulation, cell proliferation, and hypoxia could increase the CCL28 expression to accelerate the transition from active to chronic active gastritis in the stCldn18–/– mice.

Recently, SPEM cells were suggested to be the origin of cancer stem cells.⁶⁶ Evidence also suggests that prolonged gastritis eventually changes the stemness of SPEM cells.⁶⁷ In the stCldn18–/– mice, the expression levels of stemness markers were increased from middle age, when chronic active gastritis was induced. Therefore, we speculate that the stCldn18 deficiency–induced chronic active gastritis promoted tumor-directed changes in the SPEM cells.

The EMT upregulates cell migration and invasion in cancer development.⁶⁸ In this respect, we observed that CXCL5, a downstream target of Wnt signaling and an EMT-inducible cytokine, was increased during the stCldn18–/– mouse gastric tumorigenesis. Although invasive gastric cancer did not form in the stCldn18–/– mice, EMT presumably caused some morphological changes in the gastric glands to accelerate the tumorigenesis.

The expression of CXCL5, a target of Wnt signaling, was dramatically increased in the DM mice at middle age (40 w.o.). However, the CXCL5 expression was not increased in DM mice at a young age (8 w.o.), when severe gastritis was not observed. These findings suggested that the chronic active gastritis induced by stCldn18 deficiency dramatically potentiated the effect of Wnt signaling. Consistent with this possibility, the CXCL5 expression was upregulated in stCldn18–/– mice especially at old age. Thus, changes in the characteristics of the stCldn18-deficiency–induced gastritis might be required for the activation of Wnt signaling to accelerate the gastric tumorigenesis. As Wnt signaling is reported to be coordinated with Notch to regulate gastric stem cell proliferation and differentiation, it is possible that the upregulation of Notch is also involved in the stCldn18–/– mouse gastric tumorigenesis.⁶⁹

Fox’s group recently reported that gastric pathologies including gastritis and gastric tumors were observed in their Cldn18–/– mice, similar to our stCldn18–/– mice.²⁷ They globally analyzed the signaling pathways by RNA sequencing, and, like us, found that Wnt signaling was involved in the Cldn18–/– mouse gastric tumorigenesis.²⁷ In our study, we further used DM mice to examine the tumorigenic roles of Wnt signaling under the chronic gastritis induced by stCldn18 deficiency.

It was recently reported that in lung-type Cldn18 gene knockout (luCldn18–/–) mice, luCldn18 loss induced the nuclear localization of YAP, which promoted the development of lung adenocarcinoma.⁷⁰ Although the luCldn18 expression that was upregulated in the stomach of our stCldn18–/– mice, ¹⁴ the nuclear localization of YAP could might be related to the gastric tumorigenesis in our stCldn18–/– mice.

Collectively, we found that the stCldn18 deficiency induced the development of gastric tumors under chronic active gastritis in the absence of H pylori infection. Age-dependent changes in several signaling networks involving inflammation-, stemness-, and Wnt-related pathways, may accelerate this gastric tumorigenesis in a multi-faceted manner.

Materials and Methods

Ethics Statement

Animal experiments were performed in accordance with protocols approved by the Animal Studies Committee of Osaka University School of Medicine. Recombinant DNA experiments were carried out in accordance with protocols approved by Osaka University. Studies using human samples were performed at Hiroshima University in accordance with protocols approved by the Hiroshima University School of Medicine Ethics Committee.

Antibodies

Antibodies used for immunochemical staining and fluorescence-activated cell sorting (FACS) analyses are listed in Table 1.

Table 1.

Antibodies Used in Immunofluorescence Images and FACS Analysis

Epitope	Supplier	Catalog number	Conjugate
Ki-67	Santa Cruz Biotechnology	sc-7846	Unconjugate
H,K-ATPase	MBL	D031-3	Unconjugate
Gr-1	BD Pharmingen	553123	Unconjugate
CD3	BD Pharmingen	555273	Unconjugate
CXCL5	Bioss Antibodies	bs-2549R	Unconjugate
CXCL5	Cell Signaling Technology	MAB433	Unconjugate
CCL28	BioLegend	525802	Unconjugate
TFF2	Bioss Antibodies	bs-1921R	Unconjugate
Pepsin C	Santa Cruz Biotechnology	sc-51188	Unconjugate
CD44	BioLegend	103001	Unconjugate
TLR2	BioLegend	121802	Unconjugate
E-cadherin	Dr. Masatoshi Takeichi	ECCD-2	Unconjugate
α-catenin	Sigma	C-2081	Unconjugate
ZO-2	Santa Cruz Biotechnology	sc-8148	Unconjugate
Claudin-2	Immuno-Biological Laboratories	18825	Unconjugate
Claudin-4	Invitrogen	364800	Unconjugate
Claudin-7	Invitrogen	349100	Unconjugate
Claudin-18	LifeSpan BioSciences	LS-C146633	Unconjugate
Villin	Santa Cruz Biotechnology	sc-7672	Unconjugate
Active β-catenin	Cell Signaling Technology	88145	Unconjugate
CD4	BioLegend	100515	APC
CD8a	BioLegend	100723	Alexa488
CD11b	BioLegend	101217	Alexa488
Ly-6G	BioLegend	127613	APC

Open in a new tab

Generation of stCldn18–/–, Wnt1-Tg, and Wnt1-Tg stCldn18–/– DM Mice

The method for generating stCldn18-deficient (stCldn18–/–) mice was previously reported.¹⁴ In brief, the first exon of the mouse stCldn18 locus was replaced with a neomycin-resistance gene by a conventional homologous recombination technique. The obtained heterogeneous, A129 R1 ES cells were injected into ICR blastocysts, and transplanted into the ovaries of foster mother mice. The high-percentage male chimeras were bred with female C57BL/6J mice, and the resulting heterogeneous mice were intercrossed to generate stCldn18–/– mice.

The method for generating Wnt1-Tg mice was previously reported.⁶¹ Briefly, Wnt1 complementary DNA was excised and cloned into pBluescript (Stratagene, La Jolla, CA) to construct a pK19-Wnt1 transgenic vector. The transgenic vector was microinjected into fertilized eggs of F1 (C3H and C57BL/6) hybrid females, which were crossed with C57BL/6 males to generate Wnt1-Tg mice. Wnt1 transgene expression driven under keratin 19 (K19) promotor is transcriptionally active in the gastric epithelium.⁶¹

stCldn18–/– and Wnt1-Tg mice were intercrossed to generate Wnt1-Tg stCldn18–/– DM mice.

Mice were bred in specific pathogen-free conditions, and were negative for H pylori.

Histological Staining

For the immunohistological staining of paraffin sections, a freshly excised mouse stomach was fixed with 10% neutral buffered formalin solution at 4°C for 24 hours. After fixation, the stomach was dehydrated in a graded ethanol series and embedded in paraffin using a Spin Tissue Processor (Thermo Scientific, Tokyo, Japan). The samples in paraffin were cut into 5-μm-thick sections, deparaffinized twice by immersion in xylene at room temperature for 3 minutes, and hydrated by being passed through a series of decreasing ethanol concentrations (100%, 95%, 90%, 80%, 70%, and 50%) at room temperature for 1 minute each. The samples were then blocked with phosphate-buffered saline (PBS) containing 1% bovine serum albumin at room temperature for 10 minutes, and stained with primary antibodies at 4°C overnight. After 3 washes with PBS, the samples were stained with Horseradish peroxidase (HRP)-labeled secondary antibodies for 1 hour at room temperature. After 3 washes with PBS, the samples were developed with 3,3’-Diaminobenzidine tetrahydrochloride (DAB) at room temperature for 10 minutes. The samples were then rinsed with running tap water for 5 minutes. After counterstaining with hematoxylin, the samples were dehydrated, and mounted with Marinol (Muto Pure Chemicals Co, Ltd, Tokyo, Japan; Cat. No. 20091).

For the immunofluorescence staining of frozen sections, the mouse stomach was washed with ice-cold PBS, embedded in Tissue-Tek O.C.T. Compound (Sakura Finetek Japan Co, Ltd, Tokyo, Japan; Cat. No. 4583), and was frozen in liquid N₂. The frozen samples were cut into 5-μm-thick sections, and air dried at room temperature for 20 minutes. The sections were fixed with methanol at –20°C for 10 minutes, or with PBS containing 2% paraformaldehyde at room temperature for 10 minutes after permeabilization with PBS containing 0.1% Triton-X100 at room temperature for 10 minutes. The samples were then blocked with PBS containing 1% bovine serum albumin at room temperature for 10 minutes. After blocking, the samples were stained with primary antibody overnight at 4°C. After 3 washes with PBS, the samples were stained with fluorescently labeled secondary antibodies and with 1 mg/mL 4′,6-diamidino-2-phenylindole (DAPI) for 1 hour at room temperature. After 3 washes with PBS and 1 with deionized distilled water, the samples were embedded in fluorescence mounting medium (Dako Japan, Tokyo, Japan; Cat. No. S3023).

For the immunofluorescent staining of paraffin sections, deparaffinized and hydrated 5-μm-thick sections were prepared as described above. The samples then underwent antigen retrieval in deionized distilled water containing 0.5% Immunosaver (Nissin EM, Tokyo, Japan) at 98°C for 45 minutes. After antigen retrieval, the samples were washed 3 times with PBS. The samples were then blocked, and stained with appropriate antibodies as described above.

Microscopy

Immunofluorescent images were captured or tiled by an LSM710 confocal laser-scanning microscope (Carl Zeiss Japan, Tokyo, Japan) equipped with a 405-nm blue diode laser, 488-nm argon laser, 561-nm DPSS laser, and 633-nm HeNe laser, and with a Plan-Apochromat 20×/0.8 M27 objective, C-Apochromat 40×/1.2 W Corr M27 objective, and C-Apochromat 63×/1.20 W Corr M27 objective. The acquired images were analyzed by ZEN 2012 (Carl Zeiss Japan).

Bright field images were captured or tiled by a BZ-X700 all-in-1 microscope (Keyence Japan, Osaka, Japan) equipped with CFI Plan Apo λ4x, CFI Plan Apo λ10x, CFI Plan Apo λ20x, and CFI Plan Apo λ40x objectives. The acquired images were analyzed by a BZ-X Analyzer (Keyence Japan).

Flow Cytometry

A glandular portion of a freshly excised mouse stomach was washed with cold PBS, and minced with scissors. The minced tissue was washed twice with cold PBS and centrifuged at 600 g at 4°C for 5 minutes, then incubated in 20 mL of Hank’s balanced salt solution (HBSS) containing 10% fetal bovine serum (FBS), 50-mM EDTA, and 15-mg/mL dithiothreitol at 37°C for 10 minutes. After centrifugation at 600 g at room temperature for 10 minutes, the tissue was resuspended and incubated in HBSS containing 300 U/mL collagenase type 1 (Worthington Biochemical Corporation, Lakewood, NJ; Cat. No. LS004196), 0.01/mg/mL DNase 1 (Roche Diagnostics, Tokyo, Japan; Cat. No. 10104159001), and 10% FBS at 37°C for 50 minutes with intermittent pipetting. The recovered cells were sequentially filtered using a 100-, 40-, and 10-μm-pore-sized nylon mesh. After filtration, the single-cell suspension was blocked with HBSS containing 1% FBS (FBS/HBSS), and stained with fluorescently labeled antibodies at 4°C for 30 minutes. After staining, the cell suspension was washed 3 times with HBSS, each followed by centrifugation at 300 g at 4°C for 5 minutes. The final cell pellet was resuspended in 1% FBS/HBSS containing 1-μg/mL propidium iodide (Nacalai tesque, Kyoto, Japan; Cat. No. 29037-92). The cell suspension was analyzed using a BD FACSCanto II (BD Biosciences Japan, Tokyo, Japan) and FlowJo software (FlowJo LLC, Ashland, OR).

Quantitative Real-Time Polymerase Chain Reaction

A freshly excised mouse stomach was cut into small pieces, which were quickly immersed into 500 μL of RNAlater (Sigma-Aldrich Japan, Tokyo, Japan; Cat. No. R0901-500ML). The stomach tissue was then frozen in liquid N₂, fractured using an SK-100 mill (Tokken, Inc, Chiba, Japan), and processed for RNA isolation. The total RNA was isolated using an RNeasy Mini Kit (Qiagen, Tokyo, Japan; Cat. No. 74106), and complementary DNA was synthesized using ReverTraAce (Toyobo, Osaka, Japan; Cat. No. TRT-101) according to the manufacturers’ instructions. Quantitative RT-PCR (qRT-PCR) was performed using the QuantiTect SYBR Green PCR Kit (Qiagen; Cat. No. 204143), and the 7900HT Fast Real-Time PCR System (Applied Biosystems Japan, Tokyo, Japan). The oligonucleotide sequences for qRT-PCR are listed in Table 2.

Table 2.

Primer Sequences for Quantitative Real-Time PCR

Gene	Forward primer	Reverse primer
IL-1b	GCCTCGTGCTGTCGGACC	TGTCGTTGCTTGGTTCTCCTTG
TNF-a	AGGCTGCCCCGACTACGT	GACTTTCTCCTGGTATGAGATAGCAAA
CXCL1	TGAGCTGCGCTGTCAGTGCCT	AGAAGCCAGCGTTCACCAGA
CXCL5	GCATTTCTGTTGCTGTTCACGCTG	CCTCCTTCTGGTTTTTCAGTTTAGC
CCL28	GAAGCGCATGGAGCTCTGA	AGCTAGGTGGATCTCTGTGAGTTTG
STAT3	GGATCGCTGAGGTACAACCC	GTCAGGGGTCTCGACTGTCT
NFkB	GAAATTCCTGATCCAGACAAAAAC	ATCACTTCAATGGCCTCTGTGTAG
IKKb	TTCCAGCTGAGGAAAGTG TG	AGCTGTTATTCCGGAGGAGA
ASCL2	GCCTACTCGTCGGAGGAA	CCAACTGGAAAAGTCAAGCA
TLR2	AACCTCAGACAAAGCGTCAAATC	ACCAAGATCCAGAAGAGCCAAA
c-Myc	ATGCCCCTCAACGTGAACTTC	CGGAGTCGTAGTCGAGGTCATA
HIF2a	TGAGTTGGCTCATGAGTTGC	TTGCTGATGTTTTCCGACAG
MMP7	AGGTGTGGAGTGCCAGATGTTG	CCACTACGATCCGAGGTAAGTC
sox2	GGCAGCTACAGCATGATGCAGGAGC	CTGGTCATGGAGTTGTACTGCAGG
Wnt1	AAATGGCAATTCCGAAACC	GAAGATGAACGCTGTTTCTCG
Wnt2	AAATGGCAATTCCGAAACC	GAGGTGATTGCGAAGATGAA
Wnt3	AGGAGTGCCAGCATCAGTTC	ACTTCCAGCCTTCTCCAGGT
Wnt4	CTGGAGAAGTGTGGCTGTGA	CAGCCTCGTTGTTGTGAAGA
Wnt5	CAAATAGGCAGCCGAGAGAC	CTCTAGCGTCCACGAACTCC
mCldn-1	CTGGAAGATGATGAGGTGCAGAAGA	CCACTAATGTCGCCAGACCTGAA
mCldn-2	ATACTACCCTTTAGCCCTGACCGAGA	CAGTAGGAGCACACATAACAGCTACCAC
mCldn-3	CACCACTACCAGCAGTCGATGAAC	AGACTGTGTGTCGTCTGTCACCATC
mCldn-4	GGTAGCTCAGCTGTGACTTTGGACTC	CTGGAGTAACGTGTAGGCTGAGTGAG
mCldn-5	TAACCTGAAAGGGCAGCTGGAGAAAC	AGGTCCAGGCTAAGTCCTTTGGTTCAGTAG
mCldn-6	TGCCCACTCTATCATCCAGGACTTC	AGGCCTGAGGCTGCCCAG
mCldn-7	ACGCCCATGAACGTTAAGTACGAG	CTTTGCTTTCACTGCCTGGACA
mCldn-8	CTGGGGATAAAAGAGAAGGAGGCTGA	AGGCTGCAAAGCAGGATAGCAGAAAG
mCldn-9	CTTGAGCTAACCCTCTGTAGTGGTTG	CCAGAGTAAGAAAGTCCAGGAGAGCA
mCldn-10.1	TGGGTGCTAGTGTCTTCCACACTG	GAATCGGTAACGCAGATCTTCCAC
mCldn-10.2	TCCCACACTTCAAGCCATGAGA	GCAGACACTGGACAAAACTTCCAC
mCldn-11	CTGCCGAAAAATGGACGAACTG	TGCACGTAGCCTGGAAGGATGA
mCldn-12	CAGACCAGTGTGTACTCAGACTTTCTACCC	GAAGCAACATACTGACTGTCTCCTGACG
mCldn-13	GTCAACATCCCAGTATGCAGAGACTTTC	GCTGGCCATCAAACATCTAAGGTATC
mCldn-14	GCAGCGTTGATAGCTGAAACTAGGTG	CCAAGGCTGCTAGAAACTTTGCTG
mCldn-15	GCAGGGACCCTCCACATACTTG	AGTTCATACTTGGTTCCAGCATACAGTG
mCldn-16	CTGGAGGTGAGCACTAAATGCAGAG	AGTTACCACCAGCTTCAAGGGATGTTC
mCldn-17	CTTCCACCAGCTACGTCTAAGGCTTACTTC	CTGAAGTACTCACAGTTTCTGGGGTGAC
mCldn-18-1.2A	AGTATGAAGGGCTCTGGAGGAGTTG	AGAACAATGCCCACGATCATCAG
mCldn-18-2.1A	GTATTCAACTACCAAGGGCTATGGCGTTC	ATCATCAGGGCTCGTACAGCTTGC
mCldn-19	CAGGTCTCTGTACTTTGACTGCTGTCTC	CCAAATTCGTACCTGGCATTGAC
mCldn-20	GGTACACCAAGGAGATCATAGCGAAC	ATGTACAGGGCTCCTCCAGGTTCATA
mClaudin21	CTGGGACTATTGGGACTTCTG	AGGAGACTGGAAAGAGGGTAG
mCldn22	CTCCCAGAACGTTCTAATGGGCTTAG	AGTGCGGCAAGTAGTTTGTAAGGCAG
mCldn-23	TGGAGTCTGAGGGTGACTTGAACTTCTG	AAGGAAGGCTTGACCTCCAGTTAGAGGAAG
mClaudin24	GATCATGGTTCATACCTAG	TAAGGACACGACTCGGC
mClaudin25	ACGAGCAGTTCATGGAGAAG	CAAAGCACATCAAGCCCAAG
mClaudin26	ATGAACCCTTTCTGGCAGG	AACACCATCACGATCAGACTG
mClaudin27	ATCGTATGTGGTTGGGTCTG	GGTGTGAGTAGCTGATGTAGATG

Open in a new tab

POL7085 and Cimetidine Administration

POL7085 (Polyphor Ltd, Allschwil, Switzerland) (15 mg/kg body weight/250 μL in saline containing 0.03% dimethyl sulfoxide, each day), or cimetidine (Nacalai tesque; Cat. No.09031-14) (20 mg/kg body weight/250 μL in saline containing 0.05% methanol, each day) were intraperitoneally administered to around 50 w.o. mice using a 1-mL syringe (Terumo, Tokyo, Japan; Cat. No. SS-01T) with a 27-gauge needle (Terumo; Cat. No. NN-2719S). Saline containing 0.03% dimethyl sulfoxide or 0.05% methanol was used as the vehicle control. After 1 week of daily administration, the mouse stomach was excised and subjected to qRT-PCR analysis as described above.

Statistical Analysis

All data were expressed as the mean ± SD. Comparisons between 2 groups were performed using Student’s t test, and differences with P < .05 were considered statistically significant. Comparisons among more than 3 groups were performed using the Kruskal-Wallis 1-way analysis of variance on ranks (P < .01) followed by the Steel-Dwass test.

Acknowledgments

The authors thank our laboratory members for helpful discussions. The authors also thank Polyphor Ltd for supplying their product POL7085, protein epitope mimetic -CCR10 antagonist.

Footnotes

Author contributions S. Koya, S. Kazuhiro, T. Hiroo: acquisition of data; analysis and interpretation of data; drafting of the manuscript; critical revision of the manuscript for important intellectual content; statistical analysis; technical or material support. Y. Tomoki, S. Kazuo, O. Masanobu, Y. Wataru: critical revision of the manuscript for important intellectual content; study supervision. S. Koya, T. Atsushi, T. Sachiko: study concept and design; analysis and interpretation of data; drafting of the manuscript; critical revision of the manuscript for important intellectual content; technical or material support.

Conflicts of interest The authors disclose no conflicts.

Funding This research was supported by Core Research for Evolutionary Science and Technology CREST of the Japan Science and Technology Agency (JST) (to Sachiko Tsukita), Grant-in-Aid for Scientific Research of Innovative Areas from the Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan (to Sachiko Tsukita), and Grant-in-Aid for Scientific Research (A) (to Sachiko Tsukita) and (B) (to Atsushi Tamura) from Japan Society for the Promotion of Science (JSPS) of Japan, and the Takeda Science Foundation in Japan (to Sachiko Tsukita), and Project Mirai Cancer Research Grants in Japan (to Sachiko Tsukita).

Contributor Information

Koya Suzuki, Email: koya-suzuki@juntendo.ac.jp.

Atsushi Tamura, Email: atamura@biosci.med.osaka-u.ac.jp.

Sachiko Tsukita, Email: atsukita@biosci.med.osaka-u.ac.jp.

References

1.Correia A.L., Bissell M.J. The tumor microenvironment is a dominant force in multidrug resistance. Drug Resist Updat. 2012;15:39–49. doi: 10.1016/j.drup.2012.01.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
2.Fidler I.J., Kripke M.L. Metastasis results from preexisting variant cells within a malignant tumor. Science. 1977;197:893–895. doi: 10.1126/science.887927. [DOI] [PubMed] [Google Scholar]
3.Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat Rev Cancer. 2009;9:239–252. doi: 10.1038/nrc2618. [DOI] [PMC free article] [PubMed] [Google Scholar]
4.Bhat R., Bissell M.J. Of plasticity and specificity: dialectics of the microenvironment and macroenvironment and the organ phenotype. Wiley Interdiscip Rev Membr Transp Signal. 2014;3:147–163. doi: 10.1002/wdev.130. [DOI] [PMC free article] [PubMed] [Google Scholar]
5.Frank J.A. Claudins and alveolar epithelial barrier function in the lung. Ann N Y Acad Sci. 2012;1257:175–183. doi: 10.1111/j.1749-6632.2012.06533.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
6.Abu-Odeh M., Bar-Mag T., Huang H., Kim T.H., Salah Z., Abdeen S.K., Sudol M., Reichmann D., Sidhu S., Kim P.M., Aqeilan R.I. Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks. J Biol Chem. 2014;289:8865–8880. doi: 10.1074/jbc.M113.506790. [DOI] [PMC free article] [PubMed] [Google Scholar]
7.Tsukita S., Furuse M., Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol. 2001;2:285–293. doi: 10.1038/35067088. [DOI] [PubMed] [Google Scholar]
8.Shen L. Tight junctions on the move: molecular mechanisms for epithelial barrier regulation. Ann N Y Acad Sci. 2012;1258:9–18. doi: 10.1111/j.1749-6632.2012.06613.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
9.Suzuki H., Tani K., Tamura A., Tsukita S., Fujiyoshi Y. Model for the architecture of claudin-based paracellular ion channels through tight junctions. J Mol Biol. 2015;427:291–297. doi: 10.1016/j.jmb.2014.10.020. [DOI] [PubMed] [Google Scholar]
10.Peek R.M., Jr., Blaser M.J. Hellicobactor pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2016;2:387–402. doi: 10.1038/nrc703. [DOI] [PubMed] [Google Scholar]
11.Higashi H., Nakaya A., Tsutstumi R., Yokoyama K., Fujii Y., Ishikawa S., Higuchi M., Takahashi A., Kurashima Y., Teishikata Y., Tanaka S., Azuma T., Hatakeyama M. Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J Biol Chem. 2004;279:17205–17216. doi: 10.1074/jbc.M309964200. [DOI] [PubMed] [Google Scholar]
12.Takahashi A., Tsutsumi R., Kikuchi I., Obuse C., Saito Y., Seidi A., Karisch R., Fernandez M., Cho T., Ohnishi N., Rozenblatt-Rosen O., Meyerson M., Neel B.G., Hatakeyama M. SHP2 tyrosine phosphatase converts parafibromin/Cdc73 from a tumor suppressor to an oncogenic driver. Mol Cell. 2011;43:45–56. doi: 10.1016/j.molcel.2011.05.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
13.Saadat I., Higashi H., Obuse C., Umeda M., Murata-Kamiya N., Saito Y., Lu H., Ohnishi N., Azuma T., Suzuki A., Ohno S., Hatakeyama M. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature. 2007;447:330–333. doi: 10.1038/nature05765. [DOI] [PubMed] [Google Scholar]
14.Hayashi D., Tamura A., Tanaka H., Yamazaki Y., Watanabe S., Suzuki K., Suzuki K., Sentani K., Yasui W., Rakugi H., Isaka Y., Tsukita S. Deficiency of claudin–18 causes paracellular H+leakage, upregulation of interleukin–1β, and atrophic gastritis in mice. Gastroenterology. 2012;142:292–304. doi: 10.1053/j.gastro.2011.10.040. [DOI] [PubMed] [Google Scholar]
15.Mineta K., Yamamoto Y., Yamazaki Y., Tanaka H., Tada Y., Saito K., Tamura A., Igarashi M., Endo T., Takeuchi K., Tsukita S. Predicted expansion of the claudin multigene family. FEBS Lett. 2011;585:606–612. doi: 10.1016/j.febslet.2011.01.028. [DOI] [PubMed] [Google Scholar]
16.Tsukita S., Furuse M., Itoh M. Structural and signalling molecules come together at tight junctions. Curr Opin Cell Biol. 1999;11:628–633. doi: 10.1016/s0955-0674(99)00016-2. [DOI] [PubMed] [Google Scholar]
17.Tanaka H., Takechi M., Kiyonari H., Shioi G., Tamura A., Tsukita S. Intestinal deletion of claudin-7 enhances paracellular organic solute flux and initiates colonic inflammation in mice. Gut. 2015;64:1529–1538. doi: 10.1136/gutjnl-2014-308419. [DOI] [PubMed] [Google Scholar]
18.Matsumoto K., Imasato M., Yamazaki Y., Tanaka H., Watanabe M., Eguchi H., Nagano H., Hikita H., Tatsumi T., Takehara T., Tamura A., Tsukita S. Claudin 2 deficiency reduces bile flow and increases susceptibility to cholesterol gallstone disease in mice. Gastroenterology. 2014;147:1134–1145.e10. doi: 10.1053/j.gastro.2014.07.033. [DOI] [PubMed] [Google Scholar]
19.Wada M., Tamura A., Takahashi N., Tsukita S. Loss of claudins 2 and 15 from mice causes defects in paracellular Na+flow and nutrient transport in gut and leads to death from malnutrition. Gastroenterology. 2013;144:369–380. doi: 10.1053/j.gastro.2012.10.035. [DOI] [PubMed] [Google Scholar]
20.Tamura A., Tsukita S. Paracellular barrier and channel functions of TJ claudins in organizing biological systems: advances in the field of barriology revealed in knockout mice. Semin Cell Dev Biol. 2014;36:177–185. doi: 10.1016/j.semcdb.2014.09.019. [DOI] [PubMed] [Google Scholar]
21.Tokumasu R., Yamaga K., Yamazaki Y., Murota H., Suzuki K., Tamura A., Bando K., Furuta Y., Katayama I., Tsukita S. Dose-dependent role of claudin–1 in vivo in orchestrating features of atopic dermatitis. Proc Natl Acad Sci U S A. 2016;113:E4061–E4068. doi: 10.1073/pnas.1525474113. [DOI] [PMC free article] [PubMed] [Google Scholar]
22.Van Itallie C.M., Anderson J.M. Claudins and epithelial paracellular transport. Annu Rev Physiol. 2006;68:403–429. doi: 10.1146/annurev.physiol.68.040104.131404. [DOI] [PubMed] [Google Scholar]
23.Guillemot L., Paschoud S., Pulimeno P., Foglia A., Citi S. The cytoplasmic plaque of tight junctions: a scaffolding and signalling center. Biochim Biophys Acta. 2008;1778:601–613. doi: 10.1016/j.bbamem.2007.09.032. [DOI] [PubMed] [Google Scholar]
24.Yao F., Kausalya J.P., Sia Y.Y., Teo A.S.M., Lee W.H., Ong A.G.M., Zhang Z., Tan J.H.J., Li G., Bertrand D., Liu X., Poh H.M., Guan P., Zhu F., Pathiraja T.N., Ariyaratne P.N., Rao J., Woo X.Y., Cai S., Mulawadi F.H., Poh W.T., Veeravalli L., Chan C.S., Lim S.S., Leong S.T., Neo S.C., Choi P.S., Chew E.G., Nagarajan N., Jacques P.E., So J.B., Ruan X., Yeoh K.G., Tan P., Sung W.K., Hunziker W., Ruan Y., Hillmer A.M. Recurrent fusion genes in gastric cancer: CLDN18-ARHGAP26 induces loss of epithelial integrity. Cell Rep. 2015;12:272–285. doi: 10.1016/j.celrep.2015.06.020. [DOI] [PubMed] [Google Scholar]
25.Tsukita S., Tanaka H., Tamura A. The claudins: from tight junctions to biological systems. Trends Biochem Sci. 2019;44:141–152. doi: 10.1016/j.tibs.2018.09.008. [DOI] [PubMed] [Google Scholar]
26.Multhoff G., Molls M., Radons J. Chronic inflammation in cancer development. Front Immunol. 2012;2:1–17. doi: 10.3389/fimmu.2011.00098. [DOI] [PMC free article] [PubMed] [Google Scholar]
27.Hagen S.J., Ang L.-H., Zheng Y., Karahan S.N., Wu J., Wang Y.E., Caron T.J., Gad A.P., Muthupalani S., Fox J.G. Loss of tight junction protein Claudin 18 promotes progressive neoplasia development in mouse stomach. Gastroenterology. 2018:1–16. doi: 10.1053/j.gastro.2018.08.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
28.Zhang X.Y., Zhang P.Y., Aboul-Soud M.A.M. From inflammation to gastric cancer: role of Helicobacter pylori. Oncol Lett. 2017;13:543–548. doi: 10.3892/ol.2016.5506. [DOI] [PMC free article] [PubMed] [Google Scholar]
29.Nakagawa H., Umemura A., Taniguchi K., Font-Burgada J., Dhar D., Ogata H., Zhong Z., Valasek M.A., Seki E., Hidalgo J., Koike K., Kaufman R.J., Karin M. ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development. Cancer Cell. 2014;26:331–343. doi: 10.1016/j.ccr.2014.07.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
30.Katoh H., Wang D., Daikoku T., Sun H., Dey S.K., DuBois R.N. CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. Cancer Cell. 2013;24:631–644. doi: 10.1016/j.ccr.2013.10.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
31.Takahashi E., Nagano O., Ishimoto T., Yae T., Suzuki Y., Shinoda T., Nakamura S., Niwa S., Ikeda S., Koga H., Tanihara H., Saya H. Tumor necrosis factor-?? regulates transforming growth factor-??-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction. J Biol Chem. 2010;285:4060–4073. doi: 10.1074/jbc.M109.056523. [DOI] [PMC free article] [PubMed] [Google Scholar]
32.Yamanoi K., Arai E., Tian Y., Takahashi Y., Miyata S., Sasaki H., Chiwaki F., Ichikawa H., Sakamoto H., Kushima R., Katai H., Yoshida T., Sakamoto M., Kanai Y. Epigenetic clustering of gastric carcinomas based on dna methylation profiles at the precancerous stage: Its correlation with tumor aggressiveness and patient outcome. Carcinogenesis. 2015;36:509–520. doi: 10.1093/carcin/bgv013. [DOI] [PMC free article] [PubMed] [Google Scholar]
33.Lamouille S., Xu J., Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178–196. doi: 10.1038/nrm3758. [DOI] [PMC free article] [PubMed] [Google Scholar]
34.Zhou S.L., Zhou Z.J., Hu Z.Q., Li X., Huang X.W., Wang Z., Fan J., Dai Z., Zhou J. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling. Cancer Lett. 2015;358:124–135. doi: 10.1016/j.canlet.2014.11.044. [DOI] [PubMed] [Google Scholar]
35.Ohata H., Kitauchi S., Yoshimura N., Mugitani K., Iwane M., Nakamura H., Yoshikawa A., Yanaoka K., Arii K., Tamai H., Shimizu Y., Takeshita T., Mohara O., Ichinose M. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer. 2004;109:138–143. doi: 10.1002/ijc.11680. [DOI] [PubMed] [Google Scholar]
36.Tye H., Kennedy C.L., Najdovska M., McLeod L., McCormack W., Hughes N., Dev A., Sievert W., Ooi C.H., Ishikawa T.O., Oshima H., Bhathal P.S., Parker A.E., Oshima M., Tan P., Jenkins B.J. STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation. Cancer Cell. 2012;22:466–478. doi: 10.1016/j.ccr.2012.08.010. [DOI] [PubMed] [Google Scholar]
37.Bromberg J., Wang T.C. Inflammation and cancer: IL-6 and STAT3 complete the Link. Cancer Cell. 2009;15:79–80. doi: 10.1016/j.ccr.2009.01.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
38.Groisman G.M., Depsames R., Ovadia B., Meir A. Metastatic carcinoma occurring in a gastric hyperplastic polyp mimicking primary gastric cancer: the first reported case. Case Rep Pathol. 2014;2014:1–5. doi: 10.1155/2014/781318. [DOI] [PMC free article] [PubMed] [Google Scholar]
39.Barham W., Chen L., Tikhomirov O., Onishko H., Gleaves L., Stricker T.P., Blackwell T.S., Yull F.E. Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ. BMC Cancer. 2015;15:1–17. doi: 10.1186/s12885-015-1652-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
40.Hansson M., Hermansson M., Svensson H., Elfvin A., Hansson L.E., Johnsson E., Sjöling Å, Quiding-Järbrink M. CCL28 is increased in human Helicobacter pylori-induced gastritis and mediates recruitment of gastric immunoglobulin A-secreting cells. Infect Immun. 2008;76:3304–3311. doi: 10.1128/IAI.00041-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
41.Thomas M.A., Buelow B.J., Nevins A.M., Jones S.E., Peterson F.C., Gundry R.L., Grayson M.H., Volkman B.F. Structure-function analysis of CCL28 in the development of post-viral asthma. J Biol Chem. 2015;290:4528–4536. doi: 10.1074/jbc.M114.627786. [DOI] [PMC free article] [PubMed] [Google Scholar]
42.Facciabene A., Peng X., Hagemann I.S., Balint K., Barchetti A., Wang L.P., Gimotty P.A., Gilks C.B., Lal P., Zhang L., Coukos G. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Tregcells. Nature. 2011;475:226–230. doi: 10.1038/nature10169. [DOI] [PubMed] [Google Scholar]
43.Huaman M.A., Fiske C.T., Jones T.F., Warkentin J., Shepherd B.E., Maruri F., Sterling T.R. CCL28 chemokine: An anchoring point bridging innate and adaptive immunity. Int Immunopharmacol. 2015;143:951–959. [Google Scholar]
44.Daubeuf F., Jung F., Douglas G.J., Chevalier E., Frossard N. Protective effect of a protein epitope mimetic CCR10 antagonist, POL7085, in a model of allergic eosinophilic airway inflammation. Respir Res. 2015;16:1–11. doi: 10.1186/s12931-015-0231-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
45.Buelow B.J., Rohlfing M., Jung F., Douglas G.J., Grayson M.H. POL7085 or anti-CCL28 treatment inhibits development of post-paramyxoviral airway disease. Immun Inflamm Dis. 2017;5:98–108. doi: 10.1002/iid3.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
46.Zavros Y. Initiation and maintenance of gastric cancer: a focus on CD44 variant isoforms and cancer stem cells. Cell Mol Gastroenterol Hepatol. 2017;4:55–63. doi: 10.1016/j.jcmgh.2017.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
47.Li H., Jasper H. Gastrointestinal stem cells in health and disease: from flies to humans. Dis Model Mech. 2016;9:487–499. doi: 10.1242/dmm.024232. [DOI] [PMC free article] [PubMed] [Google Scholar]
48.Seishima R., Wada T., Tsuchihashi K., Okazaki S., Yoshikawa M., Oshima H., Oshima M., Sato T., Hasegawa H., Kitagawa Y., Goldenring J.R., Saya H., Nagano O. Ink4a/arf-dependent loss of parietal cells induced by oxidative stress promotes CD44-dependent gastric tumorigenesis. Cancer Prev Res (Phila) 2015;8:492–501. doi: 10.1158/1940-6207.CAPR-15-0025-T. [DOI] [PubMed] [Google Scholar]
49.Wada T., Ishimoto T., Seishima R., Tsuchihashi K., Yoshikawa M., Oshima H., Oshima M., Masuko T., Wright N.A., Furuhashi S., Hirashima K., Baba H., Kitagawa Y., Saya H., Nagano O. Functional role of CD44v-xCT system in the development of spasmolytic polypeptide–expressing metaplasia. Cancer Sci. 2013;104:1323–1329. doi: 10.1111/cas.12236. [DOI] [PMC free article] [PubMed] [Google Scholar]
50.Echizen K., Hirose O., Maeda Y., Oshima M. Inflammation in gastric cancer: Interplay of the COX-2/prostaglandin E2and Toll-like receptor/MyD88 pathways. Cancer Sci. 2016;107:391–397. doi: 10.1111/cas.12901. [DOI] [PMC free article] [PubMed] [Google Scholar]
51.Schuijers J., Junker J.P., Mokry M., Hatzis P., Koo B.K., Sasselli V., Van Der Flier L.G., Cuppen E., Van Oudenaarden A., Clevers H. Ascl2 acts as an R-spondin/wnt-responsive switch to control stemness in intestinal crypts. Cell Stem Cell. 2015;16:158–170. doi: 10.1016/j.stem.2014.12.006. [DOI] [PubMed] [Google Scholar]
52.Weis V.G., Goldenring J.R. Current understanding of SPEM and its standing in the preneoplastic process. Gastric Cancer. 2009;12:189–197. doi: 10.1007/s10120-009-0527-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
53.Holmes J.L., Van Itallie C.M., Rasmussen J.E., Anderson J.M. Claudin profiling in the mouse during postnatal intestinal development and along the gastrointestinal tract reveals complex expression patterns. Gene Expr Patterns. 2006;6:581–588. doi: 10.1016/j.modgep.2005.12.001. [DOI] [PubMed] [Google Scholar]
54.Petersen C.P., Mills J.C., Goldenring J.R. Murine models of gastric corpus preneoplasia. Cell Mol Gastroenterol Hepatol. 2017;3:11–26. doi: 10.1016/j.jcmgh.2016.11.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
55.Shimizu T., Choi E., Petersen C.P., Noto J.M., Romero-Gallo J., Piazuelo M.B., Washington M.K., Peek R.M., Goldenring J.R. Characterization of progressive metaplasia in the gastric corpus mucosa of Mongolian gerbils infected with Helicobacter pylori. J Pathol. 2016;239:399–410. doi: 10.1002/path.4735. [DOI] [PMC free article] [PubMed] [Google Scholar]
56.Chiurillo M.A. Role of the Wnt/β-catenin pathway in gastric cancer: an in-depth literature review. World J Exp Med. 2015;5:84–102. doi: 10.5493/wjem.v5.i2.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
57.Mao J., Fan S., Ma W., Fan P., Wang B., Zhang J., Wang H., Tang B., Zhang Q., Yu X., Wang L., Song B., Li L. Roles of Wnt/β-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment. Cell Death Dis. 2014;5:1–9. doi: 10.1038/cddis.2013.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
58.Brabletz T., Jung A., Dag S., Hlubek F., Kirchner T. B-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol. 1999;155:1033–1038. doi: 10.1016/s0002-9440(10)65204-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
59.Zhao J., Ou B., Han D., Wang P., Zong Y., Zhu C., Liu D., Zheng M., Sun J., Feng H., Lu A. Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways. Mol Cancer. 2017;16:1–15. doi: 10.1186/s12943-017-0629-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
60.Valkenburg K.C., Graveel C.R., Zylstra-Diegel C.R., Zhong Z., Williams B.O. Wnt/β-catenin signaling in normal and cancer stem cells. Cancers. 2011;3:2050–2079. doi: 10.3390/cancers3022050. [DOI] [PMC free article] [PubMed] [Google Scholar]
61.Oshima H., Matsunaga A., Fujimura T., Tsukamoto T., Taketo M.M., Oshima M. Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway. Gastroenterology. 2006;131:1086–1095. doi: 10.1053/j.gastro.2006.07.014. [DOI] [PubMed] [Google Scholar]
62.Markowski A.R., Markowska A., Guzinska-Ustymowicz K. Pathophysiological and clinical aspects of gastric hyperplastic polyps. World J Gastroenterol. 2016;22:8883–8891. doi: 10.3748/wjg.v22.i40.8883. [DOI] [PMC free article] [PubMed] [Google Scholar]
63.Velázquez-Dohorn M.E., López-Durand C.F., Gamboa-Domínguez A. Changing trends in gastric polyps. Rev Invest Clin. 2018;70:40–45. doi: 10.24875/RIC.17002430. [DOI] [PubMed] [Google Scholar]
64.Kopacova M., Tacheci I., Rejchrt S., Bures J. Peutz-Jeghers syndrome: diagnostic and therapeutic approach. World J Gastroenterol. 2009;15:5397–5408. doi: 10.3748/wjg.15.5397. [DOI] [PMC free article] [PubMed] [Google Scholar]
65.Phesse T.J., Sansom O.J. Lgr5 joins the club of gastric stem cell markers in the corpus. Nat Cell Biol. 2017;19:752–754. doi: 10.1038/ncb3567. [DOI] [PubMed] [Google Scholar]
66.Leushacke M., Tan S.H., Wong A., Swathi Y., Hajamohideen A., Tan L.T., Goh J., Wong E., Denil S.L.I.J., Murakami K., Barker N. Lgr5-expressing chief cells drive epithelial regeneration and cancer in the oxyntic stomach. Nat Cell Biol. 2017;19:774–786. doi: 10.1038/ncb3541. [DOI] [PubMed] [Google Scholar]
67.Kinoshita H., Hayakawa Y., Koike K. Metaplasia in the stomach—precursor of gastric Cancer? Int J Mol Sci. 2017;18:E2063. doi: 10.3390/ijms18102063. [DOI] [PMC free article] [PubMed] [Google Scholar]
68.Mittal V. Epithelial mesenchymal transition in tumor metastasis. Annu Rev Pathol. 2018;13:395–412. doi: 10.1146/annurev-pathol-020117-043854. [DOI] [PubMed] [Google Scholar]
69.Demitrack E.S., Samuelson L.C. Notch as a driver of gastric epithelial cell proliferation. Cell Mol Gastroenterol Hepatol. 2017;3:323–330. doi: 10.1016/j.jcmgh.2017.01.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
70.Zhou B., Crandall E.D., Borok Z., Zhou B., Flodby P., Luo J., Castillo D.R., Liu Y., Yu F., Mcconnell A., Varghese B. Claudin-18 – mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis Find the latest version: Claudin-18 – mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis. J Clin Invest. 2018;128:970–984. doi: 10.1172/JCI90429. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib1] 1.Correia A.L., Bissell M.J. The tumor microenvironment is a dominant force in multidrug resistance. Drug Resist Updat. 2012;15:39–49. doi: 10.1016/j.drup.2012.01.006. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib2] 2.Fidler I.J., Kripke M.L. Metastasis results from preexisting variant cells within a malignant tumor. Science. 1977;197:893–895. doi: 10.1126/science.887927. [DOI] [PubMed] [Google Scholar]

[bib3] 3.Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat Rev Cancer. 2009;9:239–252. doi: 10.1038/nrc2618. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib4] 4.Bhat R., Bissell M.J. Of plasticity and specificity: dialectics of the microenvironment and macroenvironment and the organ phenotype. Wiley Interdiscip Rev Membr Transp Signal. 2014;3:147–163. doi: 10.1002/wdev.130. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib5] 5.Frank J.A. Claudins and alveolar epithelial barrier function in the lung. Ann N Y Acad Sci. 2012;1257:175–183. doi: 10.1111/j.1749-6632.2012.06533.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib6] 6.Abu-Odeh M., Bar-Mag T., Huang H., Kim T.H., Salah Z., Abdeen S.K., Sudol M., Reichmann D., Sidhu S., Kim P.M., Aqeilan R.I. Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks. J Biol Chem. 2014;289:8865–8880. doi: 10.1074/jbc.M113.506790. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib7] 7.Tsukita S., Furuse M., Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol. 2001;2:285–293. doi: 10.1038/35067088. [DOI] [PubMed] [Google Scholar]

[bib8] 8.Shen L. Tight junctions on the move: molecular mechanisms for epithelial barrier regulation. Ann N Y Acad Sci. 2012;1258:9–18. doi: 10.1111/j.1749-6632.2012.06613.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib9] 9.Suzuki H., Tani K., Tamura A., Tsukita S., Fujiyoshi Y. Model for the architecture of claudin-based paracellular ion channels through tight junctions. J Mol Biol. 2015;427:291–297. doi: 10.1016/j.jmb.2014.10.020. [DOI] [PubMed] [Google Scholar]

[bib10] 10.Peek R.M., Jr., Blaser M.J. Hellicobactor pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2016;2:387–402. doi: 10.1038/nrc703. [DOI] [PubMed] [Google Scholar]

[bib11] 11.Higashi H., Nakaya A., Tsutstumi R., Yokoyama K., Fujii Y., Ishikawa S., Higuchi M., Takahashi A., Kurashima Y., Teishikata Y., Tanaka S., Azuma T., Hatakeyama M. Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J Biol Chem. 2004;279:17205–17216. doi: 10.1074/jbc.M309964200. [DOI] [PubMed] [Google Scholar]

[bib12] 12.Takahashi A., Tsutsumi R., Kikuchi I., Obuse C., Saito Y., Seidi A., Karisch R., Fernandez M., Cho T., Ohnishi N., Rozenblatt-Rosen O., Meyerson M., Neel B.G., Hatakeyama M. SHP2 tyrosine phosphatase converts parafibromin/Cdc73 from a tumor suppressor to an oncogenic driver. Mol Cell. 2011;43:45–56. doi: 10.1016/j.molcel.2011.05.014. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib13] 13.Saadat I., Higashi H., Obuse C., Umeda M., Murata-Kamiya N., Saito Y., Lu H., Ohnishi N., Azuma T., Suzuki A., Ohno S., Hatakeyama M. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature. 2007;447:330–333. doi: 10.1038/nature05765. [DOI] [PubMed] [Google Scholar]

[bib14] 14.Hayashi D., Tamura A., Tanaka H., Yamazaki Y., Watanabe S., Suzuki K., Suzuki K., Sentani K., Yasui W., Rakugi H., Isaka Y., Tsukita S. Deficiency of claudin–18 causes paracellular H+leakage, upregulation of interleukin–1β, and atrophic gastritis in mice. Gastroenterology. 2012;142:292–304. doi: 10.1053/j.gastro.2011.10.040. [DOI] [PubMed] [Google Scholar]

[bib15] 15.Mineta K., Yamamoto Y., Yamazaki Y., Tanaka H., Tada Y., Saito K., Tamura A., Igarashi M., Endo T., Takeuchi K., Tsukita S. Predicted expansion of the claudin multigene family. FEBS Lett. 2011;585:606–612. doi: 10.1016/j.febslet.2011.01.028. [DOI] [PubMed] [Google Scholar]

[bib16] 16.Tsukita S., Furuse M., Itoh M. Structural and signalling molecules come together at tight junctions. Curr Opin Cell Biol. 1999;11:628–633. doi: 10.1016/s0955-0674(99)00016-2. [DOI] [PubMed] [Google Scholar]

[bib17] 17.Tanaka H., Takechi M., Kiyonari H., Shioi G., Tamura A., Tsukita S. Intestinal deletion of claudin-7 enhances paracellular organic solute flux and initiates colonic inflammation in mice. Gut. 2015;64:1529–1538. doi: 10.1136/gutjnl-2014-308419. [DOI] [PubMed] [Google Scholar]

[bib18] 18.Matsumoto K., Imasato M., Yamazaki Y., Tanaka H., Watanabe M., Eguchi H., Nagano H., Hikita H., Tatsumi T., Takehara T., Tamura A., Tsukita S. Claudin 2 deficiency reduces bile flow and increases susceptibility to cholesterol gallstone disease in mice. Gastroenterology. 2014;147:1134–1145.e10. doi: 10.1053/j.gastro.2014.07.033. [DOI] [PubMed] [Google Scholar]

[bib19] 19.Wada M., Tamura A., Takahashi N., Tsukita S. Loss of claudins 2 and 15 from mice causes defects in paracellular Na+flow and nutrient transport in gut and leads to death from malnutrition. Gastroenterology. 2013;144:369–380. doi: 10.1053/j.gastro.2012.10.035. [DOI] [PubMed] [Google Scholar]

[bib20] 20.Tamura A., Tsukita S. Paracellular barrier and channel functions of TJ claudins in organizing biological systems: advances in the field of barriology revealed in knockout mice. Semin Cell Dev Biol. 2014;36:177–185. doi: 10.1016/j.semcdb.2014.09.019. [DOI] [PubMed] [Google Scholar]

[bib21] 21.Tokumasu R., Yamaga K., Yamazaki Y., Murota H., Suzuki K., Tamura A., Bando K., Furuta Y., Katayama I., Tsukita S. Dose-dependent role of claudin–1 in vivo in orchestrating features of atopic dermatitis. Proc Natl Acad Sci U S A. 2016;113:E4061–E4068. doi: 10.1073/pnas.1525474113. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib22] 22.Van Itallie C.M., Anderson J.M. Claudins and epithelial paracellular transport. Annu Rev Physiol. 2006;68:403–429. doi: 10.1146/annurev.physiol.68.040104.131404. [DOI] [PubMed] [Google Scholar]

[bib23] 23.Guillemot L., Paschoud S., Pulimeno P., Foglia A., Citi S. The cytoplasmic plaque of tight junctions: a scaffolding and signalling center. Biochim Biophys Acta. 2008;1778:601–613. doi: 10.1016/j.bbamem.2007.09.032. [DOI] [PubMed] [Google Scholar]

[bib24] 24.Yao F., Kausalya J.P., Sia Y.Y., Teo A.S.M., Lee W.H., Ong A.G.M., Zhang Z., Tan J.H.J., Li G., Bertrand D., Liu X., Poh H.M., Guan P., Zhu F., Pathiraja T.N., Ariyaratne P.N., Rao J., Woo X.Y., Cai S., Mulawadi F.H., Poh W.T., Veeravalli L., Chan C.S., Lim S.S., Leong S.T., Neo S.C., Choi P.S., Chew E.G., Nagarajan N., Jacques P.E., So J.B., Ruan X., Yeoh K.G., Tan P., Sung W.K., Hunziker W., Ruan Y., Hillmer A.M. Recurrent fusion genes in gastric cancer: CLDN18-ARHGAP26 induces loss of epithelial integrity. Cell Rep. 2015;12:272–285. doi: 10.1016/j.celrep.2015.06.020. [DOI] [PubMed] [Google Scholar]

[bib25] 25.Tsukita S., Tanaka H., Tamura A. The claudins: from tight junctions to biological systems. Trends Biochem Sci. 2019;44:141–152. doi: 10.1016/j.tibs.2018.09.008. [DOI] [PubMed] [Google Scholar]

[bib26] 26.Multhoff G., Molls M., Radons J. Chronic inflammation in cancer development. Front Immunol. 2012;2:1–17. doi: 10.3389/fimmu.2011.00098. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib27] 27.Hagen S.J., Ang L.-H., Zheng Y., Karahan S.N., Wu J., Wang Y.E., Caron T.J., Gad A.P., Muthupalani S., Fox J.G. Loss of tight junction protein Claudin 18 promotes progressive neoplasia development in mouse stomach. Gastroenterology. 2018:1–16. doi: 10.1053/j.gastro.2018.08.041. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib28] 28.Zhang X.Y., Zhang P.Y., Aboul-Soud M.A.M. From inflammation to gastric cancer: role of Helicobacter pylori. Oncol Lett. 2017;13:543–548. doi: 10.3892/ol.2016.5506. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib29] 29.Nakagawa H., Umemura A., Taniguchi K., Font-Burgada J., Dhar D., Ogata H., Zhong Z., Valasek M.A., Seki E., Hidalgo J., Koike K., Kaufman R.J., Karin M. ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development. Cancer Cell. 2014;26:331–343. doi: 10.1016/j.ccr.2014.07.001. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib30] 30.Katoh H., Wang D., Daikoku T., Sun H., Dey S.K., DuBois R.N. CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. Cancer Cell. 2013;24:631–644. doi: 10.1016/j.ccr.2013.10.009. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib31] 31.Takahashi E., Nagano O., Ishimoto T., Yae T., Suzuki Y., Shinoda T., Nakamura S., Niwa S., Ikeda S., Koga H., Tanihara H., Saya H. Tumor necrosis factor-?? regulates transforming growth factor-??-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction. J Biol Chem. 2010;285:4060–4073. doi: 10.1074/jbc.M109.056523. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib32] 32.Yamanoi K., Arai E., Tian Y., Takahashi Y., Miyata S., Sasaki H., Chiwaki F., Ichikawa H., Sakamoto H., Kushima R., Katai H., Yoshida T., Sakamoto M., Kanai Y. Epigenetic clustering of gastric carcinomas based on dna methylation profiles at the precancerous stage: Its correlation with tumor aggressiveness and patient outcome. Carcinogenesis. 2015;36:509–520. doi: 10.1093/carcin/bgv013. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib33] 33.Lamouille S., Xu J., Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178–196. doi: 10.1038/nrm3758. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib34] 34.Zhou S.L., Zhou Z.J., Hu Z.Q., Li X., Huang X.W., Wang Z., Fan J., Dai Z., Zhou J. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling. Cancer Lett. 2015;358:124–135. doi: 10.1016/j.canlet.2014.11.044. [DOI] [PubMed] [Google Scholar]

[bib35] 35.Ohata H., Kitauchi S., Yoshimura N., Mugitani K., Iwane M., Nakamura H., Yoshikawa A., Yanaoka K., Arii K., Tamai H., Shimizu Y., Takeshita T., Mohara O., Ichinose M. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer. 2004;109:138–143. doi: 10.1002/ijc.11680. [DOI] [PubMed] [Google Scholar]

[bib36] 36.Tye H., Kennedy C.L., Najdovska M., McLeod L., McCormack W., Hughes N., Dev A., Sievert W., Ooi C.H., Ishikawa T.O., Oshima H., Bhathal P.S., Parker A.E., Oshima M., Tan P., Jenkins B.J. STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation. Cancer Cell. 2012;22:466–478. doi: 10.1016/j.ccr.2012.08.010. [DOI] [PubMed] [Google Scholar]

[bib37] 37.Bromberg J., Wang T.C. Inflammation and cancer: IL-6 and STAT3 complete the Link. Cancer Cell. 2009;15:79–80. doi: 10.1016/j.ccr.2009.01.009. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib38] 38.Groisman G.M., Depsames R., Ovadia B., Meir A. Metastatic carcinoma occurring in a gastric hyperplastic polyp mimicking primary gastric cancer: the first reported case. Case Rep Pathol. 2014;2014:1–5. doi: 10.1155/2014/781318. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib39] 39.Barham W., Chen L., Tikhomirov O., Onishko H., Gleaves L., Stricker T.P., Blackwell T.S., Yull F.E. Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ. BMC Cancer. 2015;15:1–17. doi: 10.1186/s12885-015-1652-8. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib40] 40.Hansson M., Hermansson M., Svensson H., Elfvin A., Hansson L.E., Johnsson E., Sjöling Å, Quiding-Järbrink M. CCL28 is increased in human Helicobacter pylori-induced gastritis and mediates recruitment of gastric immunoglobulin A-secreting cells. Infect Immun. 2008;76:3304–3311. doi: 10.1128/IAI.00041-08. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib41] 41.Thomas M.A., Buelow B.J., Nevins A.M., Jones S.E., Peterson F.C., Gundry R.L., Grayson M.H., Volkman B.F. Structure-function analysis of CCL28 in the development of post-viral asthma. J Biol Chem. 2015;290:4528–4536. doi: 10.1074/jbc.M114.627786. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib42] 42.Facciabene A., Peng X., Hagemann I.S., Balint K., Barchetti A., Wang L.P., Gimotty P.A., Gilks C.B., Lal P., Zhang L., Coukos G. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Tregcells. Nature. 2011;475:226–230. doi: 10.1038/nature10169. [DOI] [PubMed] [Google Scholar]

[bib43] 43.Huaman M.A., Fiske C.T., Jones T.F., Warkentin J., Shepherd B.E., Maruri F., Sterling T.R. CCL28 chemokine: An anchoring point bridging innate and adaptive immunity. Int Immunopharmacol. 2015;143:951–959. [Google Scholar]

[bib44] 44.Daubeuf F., Jung F., Douglas G.J., Chevalier E., Frossard N. Protective effect of a protein epitope mimetic CCR10 antagonist, POL7085, in a model of allergic eosinophilic airway inflammation. Respir Res. 2015;16:1–11. doi: 10.1186/s12931-015-0231-5. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib45] 45.Buelow B.J., Rohlfing M., Jung F., Douglas G.J., Grayson M.H. POL7085 or anti-CCL28 treatment inhibits development of post-paramyxoviral airway disease. Immun Inflamm Dis. 2017;5:98–108. doi: 10.1002/iid3.147. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib46] 46.Zavros Y. Initiation and maintenance of gastric cancer: a focus on CD44 variant isoforms and cancer stem cells. Cell Mol Gastroenterol Hepatol. 2017;4:55–63. doi: 10.1016/j.jcmgh.2017.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib47] 47.Li H., Jasper H. Gastrointestinal stem cells in health and disease: from flies to humans. Dis Model Mech. 2016;9:487–499. doi: 10.1242/dmm.024232. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib48] 48.Seishima R., Wada T., Tsuchihashi K., Okazaki S., Yoshikawa M., Oshima H., Oshima M., Sato T., Hasegawa H., Kitagawa Y., Goldenring J.R., Saya H., Nagano O. Ink4a/arf-dependent loss of parietal cells induced by oxidative stress promotes CD44-dependent gastric tumorigenesis. Cancer Prev Res (Phila) 2015;8:492–501. doi: 10.1158/1940-6207.CAPR-15-0025-T. [DOI] [PubMed] [Google Scholar]

[bib49] 49.Wada T., Ishimoto T., Seishima R., Tsuchihashi K., Yoshikawa M., Oshima H., Oshima M., Masuko T., Wright N.A., Furuhashi S., Hirashima K., Baba H., Kitagawa Y., Saya H., Nagano O. Functional role of CD44v-xCT system in the development of spasmolytic polypeptide–expressing metaplasia. Cancer Sci. 2013;104:1323–1329. doi: 10.1111/cas.12236. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib50] 50.Echizen K., Hirose O., Maeda Y., Oshima M. Inflammation in gastric cancer: Interplay of the COX-2/prostaglandin E2and Toll-like receptor/MyD88 pathways. Cancer Sci. 2016;107:391–397. doi: 10.1111/cas.12901. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib51] 51.Schuijers J., Junker J.P., Mokry M., Hatzis P., Koo B.K., Sasselli V., Van Der Flier L.G., Cuppen E., Van Oudenaarden A., Clevers H. Ascl2 acts as an R-spondin/wnt-responsive switch to control stemness in intestinal crypts. Cell Stem Cell. 2015;16:158–170. doi: 10.1016/j.stem.2014.12.006. [DOI] [PubMed] [Google Scholar]

[bib52] 52.Weis V.G., Goldenring J.R. Current understanding of SPEM and its standing in the preneoplastic process. Gastric Cancer. 2009;12:189–197. doi: 10.1007/s10120-009-0527-6. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib53] 53.Holmes J.L., Van Itallie C.M., Rasmussen J.E., Anderson J.M. Claudin profiling in the mouse during postnatal intestinal development and along the gastrointestinal tract reveals complex expression patterns. Gene Expr Patterns. 2006;6:581–588. doi: 10.1016/j.modgep.2005.12.001. [DOI] [PubMed] [Google Scholar]

[bib54] 54.Petersen C.P., Mills J.C., Goldenring J.R. Murine models of gastric corpus preneoplasia. Cell Mol Gastroenterol Hepatol. 2017;3:11–26. doi: 10.1016/j.jcmgh.2016.11.001. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib55] 55.Shimizu T., Choi E., Petersen C.P., Noto J.M., Romero-Gallo J., Piazuelo M.B., Washington M.K., Peek R.M., Goldenring J.R. Characterization of progressive metaplasia in the gastric corpus mucosa of Mongolian gerbils infected with Helicobacter pylori. J Pathol. 2016;239:399–410. doi: 10.1002/path.4735. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib56] 56.Chiurillo M.A. Role of the Wnt/β-catenin pathway in gastric cancer: an in-depth literature review. World J Exp Med. 2015;5:84–102. doi: 10.5493/wjem.v5.i2.84. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib57] 57.Mao J., Fan S., Ma W., Fan P., Wang B., Zhang J., Wang H., Tang B., Zhang Q., Yu X., Wang L., Song B., Li L. Roles of Wnt/β-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment. Cell Death Dis. 2014;5:1–9. doi: 10.1038/cddis.2013.515. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib58] 58.Brabletz T., Jung A., Dag S., Hlubek F., Kirchner T. B-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol. 1999;155:1033–1038. doi: 10.1016/s0002-9440(10)65204-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib59] 59.Zhao J., Ou B., Han D., Wang P., Zong Y., Zhu C., Liu D., Zheng M., Sun J., Feng H., Lu A. Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways. Mol Cancer. 2017;16:1–15. doi: 10.1186/s12943-017-0629-4. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib60] 60.Valkenburg K.C., Graveel C.R., Zylstra-Diegel C.R., Zhong Z., Williams B.O. Wnt/β-catenin signaling in normal and cancer stem cells. Cancers. 2011;3:2050–2079. doi: 10.3390/cancers3022050. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib61] 61.Oshima H., Matsunaga A., Fujimura T., Tsukamoto T., Taketo M.M., Oshima M. Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway. Gastroenterology. 2006;131:1086–1095. doi: 10.1053/j.gastro.2006.07.014. [DOI] [PubMed] [Google Scholar]

[bib62] 62.Markowski A.R., Markowska A., Guzinska-Ustymowicz K. Pathophysiological and clinical aspects of gastric hyperplastic polyps. World J Gastroenterol. 2016;22:8883–8891. doi: 10.3748/wjg.v22.i40.8883. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib63] 63.Velázquez-Dohorn M.E., López-Durand C.F., Gamboa-Domínguez A. Changing trends in gastric polyps. Rev Invest Clin. 2018;70:40–45. doi: 10.24875/RIC.17002430. [DOI] [PubMed] [Google Scholar]

[bib64] 64.Kopacova M., Tacheci I., Rejchrt S., Bures J. Peutz-Jeghers syndrome: diagnostic and therapeutic approach. World J Gastroenterol. 2009;15:5397–5408. doi: 10.3748/wjg.15.5397. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib65] 65.Phesse T.J., Sansom O.J. Lgr5 joins the club of gastric stem cell markers in the corpus. Nat Cell Biol. 2017;19:752–754. doi: 10.1038/ncb3567. [DOI] [PubMed] [Google Scholar]

[bib66] 66.Leushacke M., Tan S.H., Wong A., Swathi Y., Hajamohideen A., Tan L.T., Goh J., Wong E., Denil S.L.I.J., Murakami K., Barker N. Lgr5-expressing chief cells drive epithelial regeneration and cancer in the oxyntic stomach. Nat Cell Biol. 2017;19:774–786. doi: 10.1038/ncb3541. [DOI] [PubMed] [Google Scholar]

[bib67] 67.Kinoshita H., Hayakawa Y., Koike K. Metaplasia in the stomach—precursor of gastric Cancer? Int J Mol Sci. 2017;18:E2063. doi: 10.3390/ijms18102063. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib68] 68.Mittal V. Epithelial mesenchymal transition in tumor metastasis. Annu Rev Pathol. 2018;13:395–412. doi: 10.1146/annurev-pathol-020117-043854. [DOI] [PubMed] [Google Scholar]

[bib69] 69.Demitrack E.S., Samuelson L.C. Notch as a driver of gastric epithelial cell proliferation. Cell Mol Gastroenterol Hepatol. 2017;3:323–330. doi: 10.1016/j.jcmgh.2017.01.012. [DOI] [PMC free article] [PubMed] [Google Scholar]

[bib70] 70.Zhou B., Crandall E.D., Borok Z., Zhou B., Flodby P., Luo J., Castillo D.R., Liu Y., Yu F., Mcconnell A., Varghese B. Claudin-18 – mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis Find the latest version: Claudin-18 – mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis. J Clin Invest. 2018;128:970–984. doi: 10.1172/JCI90429. [DOI] [PMC free article] [PubMed] [Google Scholar]

PERMALINK

Deficiency of Stomach-Type Claudin-18 in Mice Induces Gastric Tumor Formation Independent of H pylori Infection

Koya Suzuki

Kazuhiro Sentani

Hiroo Tanaka

Tomoki Yano

Kazuo Suzuki

Masanobu Oshima

Wataru Yasui

Atsushi Tamura

Sachiko Tsukita

Abstract

Background & Aims

Methods

Results

Conclusions

Graphical abstract

Summary.

Results

Induction of Oxyntic Atrophic Gastritis in Young stCldn18–/– Mice and Gastric Tumor Development in Aged stCldn18–/– Mice

Figure 1.

Irregular Differentiation and Proliferation of Gastric Epithelial Cells in Young and Aged stCldn18–/– Mice

Figure 2.

Transition From Active to Chronic Active Gastritis in Middle-Aged stCldn18–/– Mice

Figure 3.

Activation of Inflammatory Signaling including CCL28 and CXCL5 in Middle-Aged stCldn18–/– Mice

Figure 4.

Induction of Spasmolytic Polypeptide–Expressing Metaplasia in Young and Aged stCldn18–/– Mice

Figure 5.

Upregulation of CD44 Splicing Variants in Middle-Aged stCldn18–/– Mice

Figure 6.

Development of Intestinal Metaplasia and Ectopic Gastric Glands in Aged stCldn18–/– Mice

Figure 7.

Activation of Wnt Signaling in Aged stCldn18–/– Mice

Figure 8.

Acceleration of Gastric Tumorigenesis Under Chronic Active Gastritis in Wnt1-Overexpressing Transgenic stCldn18–/– Double-Mutant Mice

Figure 9.

Figure 10.

Similarity of Gastric Tumorigenesis in stCldn18–/– Mice to H pylori Infection–Related Tumorigenesis in Humans

Figure 11.

Toxic Effects of Gastric Acid in Aged stCldn18–/– Mice

Process of Gastric Tumorigenesis in Young to Aged stCldn18–/– Mice Without H pylori Infection

Figure 12.

Discussion

Materials and Methods

Ethics Statement

Antibodies

Table 1.

Generation of stCldn18–/–, Wnt1-Tg, and Wnt1-Tg stCldn18–/– DM Mice

Histological Staining

Microscopy

Flow Cytometry

Quantitative Real-Time Polymerase Chain Reaction

Table 2.

POL7085 and Cimetidine Administration

Statistical Analysis

Acknowledgments

Footnotes

Contributor Information

References

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases